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ABSTRACT 
Ashley Elizabeth Ross: Improving Routine Human Immunodeficiency Virus Screening in a 
Primary Care Setting 
(Under the direction of Jean Davison)  
 
According to the Centers for Disease Control and Prevention, in 2017, over 38,700 
people receive an human immunodeficiency virus (HIV) diagnosis in the US.  The United States 
Preventive Services Task Force (USPSTF) published recommendations in 2013 for routine HIV 
screening of patients ages 15 to 65 years old.  Primary care providers who offer routine HIV 
screening can identify patients with a positive result and promptly connect them to care to 
decrease transmission of HIV. 
 This process improvement project targeted health care providers and staff, using 
evidence-based interventions, 2013 USPSTF recommendations, and the Chronic Care Model, to 
improve HIV screening at a primary care site.  Information sessions were held with health care 
providers and staff pre- and post-intervention.  Participants were given a pre-survey (n=28) and 
post-survey (n=25) questionnaires, information on the electronic medical record screening 
reminder and educational materials about routine HIV screening.  Monthly visits were made to 
the clinic by the primary investigator who conducted semi-structured interviews with 
participants.  A retrospective chart review evaluated HIV screening data during the months of 
September, October, and November for 2017, (baseline year), compared to September - 
November 2018, intervention months. 
 The pre- and post-intervention surveys were confidential and paired by the number 
assigned to each provider participant (n=6).  The results were analyzed using descriptive 
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statistics and paired t-tests to determine if perspectives on HIV screening changed from pre- to 
post-survey.  There were no statistically significant findings from the survey questionnaire 
results, however, the mean Likert scores improved in the post-survey in most topics. 
 Twenty-five percent of encounters during the 2017 baseline months and 2018 
intervention months had an HIV test ordered.  During the 2018 intervention year, September had 
a 3.5% increase and October had a 1.0% increase in percentage of tests ordered when compared 
to 2017; however, November 2018 had a 5.8% decrease from November 2017. 
 This project piloted interventions to increase provider and clinic staff’s knowledge on 
routine HIV screening practices to help further reduce HIV transmissions among patients with an 
unknown serostatus.  Further work is needed to identify ways to improve screening rates, such as 
clinic staff-initiated screening and rapid screening.  
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE  
Introduction 
 There are over one million individuals in the United States (U.S.) living with a diagnosis 
of human immunodeficiency virus (HIV), with an estimated one out of seven being unaware of 
their diagnosis (Centers for Disease Control and Prevention [CDC], 2017a).  Individuals unaware 
of their HIV diagnosis are responsible for approximately 40% of ongoing transmissions (Dailey, 
Hoots, Hall, Song, Hayes, Fulton, Prejean, Hernandez, Koenig, Valleroy, 2017).  Delays in 
diagnosis can lead to serious consequences, such as ongoing transmission to unaffected 
individuals, decreased immune function leading to opportunistic infections, increase in morbidity 
and mortality and the likelihood of progression to acquired immunodeficiency syndrome (AIDS) 
(Dailey et al., 2017).  In 2015, the median delay in diagnosis was estimated to be three years with 
an interquartile range of 0.7-7.8 years (Dailey et al., 2017). 
 Over the past decade the “test and treat” model has evolved to regularly test adults and 
treat all HIV infected individuals with antiretroviral therapy, regardless of their cluster of 
differentiation 4 (CD4) count to aid in the elimination of HIV in society (U.S. Department of 
Health and Human Services, 2012).  The advancement in HIV care and antiretroviral 
medications have made it possible to achieve viral suppression to reduce the risk of opportunistic 
infections and progression to AIDS, thus allowing the HIV patient to live a healthy life with 
minimal risk of transmission to others (Dailey et al., 2017).  There is evidence available that 
shows if a person living with HIV (PLWHIV or PLWH) has been on antiretroviral therapy and 
had an undetected viral load for at least six months, then there is no-risk of transmitting the virus 
   
2 
to an unaffected partner, therefore, preventing new HIV infections (Eisinger, Dieffenbach & 
Fauci, 2019). 
 In addition to better outcomes and decreased transmission rates for persons who are HIV 
positive who know their status and are in treatment, there are also options for their partners who 
are HIV negative to prevent acquiring HIV if exposed (CDC, 2018).  In 2012, a single-daily dose 
of Truvada was approved for pre-exposure prophylaxis or (PrEP) therapy, which reduces the risk 
of individuals becoming infected with HIV if they are at a high-risk for infection (CDC, 2018).  
With better treatment and prevention of transmission, it is more important than ever to be 
screened and know your status; that is why both the Centers for Disease Control and Prevention 
(CDC, 2006) along with the United States Preventive Services Task Force (USPSTF, 2013) 
revised their recommendations for routine HIV screening. 
Incidence of HIV in the United States 
 The incidence of new HIV diagnoses has been on the decline over the past several years 
due to various prevention programs and advances in available treatments to decrease the rates of 
transmission (CDC, 2017d).  From 2008 to 2014, there was an 18 percent decline in the 
estimated number of new HIV diagnoses in the U.S. from 45,700 to 37,600 (CDC, 2017d).  In 
2017, a total of 38,730 individuals received a new HIV diagnosis in the U.S with 67% of the 
diagnoses from male-to-male sexual contact, 24% from heterosexual contact, six percent related 
to intravenous drug use, and three percent from male-to-male contact and intravenous drug use 
(CDC, 2018e). 
Prevalence of HIV in the United States 
The prevalence of HIV varies between different geographic regions in the United States 
along with different at-risk groups, such as men who have sex with men, intravenous drug users 
(IVDU), being in your twenties with multiple sexual partners and being African American 
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(CDC, 2018e).  Overall, people living in the South make up about 37% of the U.S. population; 
however, an estimated 44 percent of individuals living with a diagnosis of HIV reside in the 
South (CDC, 2016).  In 2017, the South had the highest prevalence of HIV, at 16.1 per 100,000 
population, with the Northeast at 10.2 per 100,000 population, followed by the West, at 9.4 per 
100,000 population.  Last, the prevalence in the Midwest was at 7.4 per 100,000 population 
(CDC, 2018a). 
North Carolina HIV Statistics 
 North Carolina is one of the 16 states in the South where both HIV prevalent and incident 
cases are much higher in relation to other parts of the country (CDC, 2016).  The number of 
individuals living in North Carolina with HIV in 2017 was 35,045, with 1,310 new diagnoses or 
incident cases, with a proportion of 15.2 per 100,000 population (North Carolina Health and 
Human Services, 2018).  In 2017, nearly 65% of HIV in men living in North Carolina was 
among men who have sex with men (North Carolina Health and Human Services, 2018).  
Individuals between the ages of 20 to 29 years old living in North Carolina accounted for 41% of 
prevalent HIV cases in 2017 (North Carolina Health and Human Services, 2018).   
 African Americans living in North Carolina have the highest disparity for HIV out of all 
other racial or ethnic groups (CDC, 2018e).  The African American population represents 64.8% 
of all HIV infections in both adolescents and adults in North Carolina (North Carolina Health 
and Human Services, 2018).  In both men and women, African Americans in North Carolina 
with HIV have the highest incidence of new HIV cases with a proportion of 45.5 per 100,000 
population (North Carolina Health and Human Services, 2018).  African American men have the 
highest proportion of HIV infections at a level of 78.0 per 100,000 population (North Carolina 
Health and Human Services, 2018). 
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Guilford County, North Carolina HIV Statistics 
 Guilford County, located in North Carolina, where this Doctor of Nursing Practice (DNP) 
project took place, is considered one of three large metropolitan areas in the state with a 
population greater than 500,000 (North Carolina Health and Human Services, 2018).  Guilford 
County is one of the top 10 counties for individuals living with HIV, with 2,597 prevalent cases 
in 2017 (North Carolina Health and Human Services, 2018).  Guilford County had a total of 124 
new HIV incident cases, with a cumulative incidence of 28.0 per 100,000 population in 2017 
(North Carolina Health and Human Services, 2018).  This number is down from the previous 
year in 2016, which had 138 new HIV incident cases (North Carolina Health and Human 
Services, 2018). 
Cost of HIV 
 Like other chronic disease diagnoses, HIV carries a burden of health care costs to patients 
for screening, treatments and long-term management of their disease (CDC, 2017b).  The 
lifetime cost of HIV treatment for each new diagnosis of HIV was estimated to be $379,668 in 
the U.S in 2010 (CDC, 2017b).  The cost of a new HIV diagnosis in 2010 varied between $1,900 
to $10,000 per diagnosis, which was based on diagnoses from clinical settings such as primary 
care practices, emergency departments, or sexually transmitted disease (STD) clinics (CDC 
2017b).  The costs of the various testing strategies used, such as rapid testing or standard testing 
via venipuncture, also play a role in cost and vary from state to state (CDC, 2017b).  The cost of 
HIV care and treatment in community-based settings varied by state from $10,334 to $20,413 per 
new diagnosis in 2010 (CDC, 2017b).  Some of the community-based settings vary in cost 
because of testing being completed in jails and the high number of inmates who test positive, and 
the cost to implement testing in jails varying from state to state.   In 2009, the total lifetime 
treatment cost for new HIV diagnoses in North Carolina was 631 million dollars, which during 
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that same year had 1,719 new HIV diagnoses (CDC, 2017b). Early diagnosis and treatment can 
decrease the number of transmissions of new cases along with the cost of illness with patients 
living with HIV (CDC, 2017b). 
Routine HIV Screening Recommendations 
The CDC Recommendations for Routine HIV Screening 
 The Centers for Disease Control and Prevention (CDC) revised their evidence-based HIV 
screening recommendations in 2006 in response to the continued increase in the number of 
individuals receiving a diagnosis of HIV after several years of living with the disease despite the 
numerous visits to a variety of health care settings (CDC, 2006).  The CDC HIV screening 
revision includes routine screening of HIV in patient’s ages 13 to 64 years old in all health care 
settings, screening all pregnant women and screening at all STD clinic visits (CDC, 2006).  The 
CDC eliminated the need for a separate written consent for HIV screening and allowed it to be a 
part of the general consent.  A separate consent was previously required, but now in many health 
systems, including where this DNP project took place, HIV screening is a part of the general 
consent for treatment that patients sign when receiving medical care (Appendix 1).  Healthcare 
providers, including advanced practice providers and physicians must disclose to patients they 
will be performing the HIV screening and allow the patient to accept or decline screening in 
what is known as “opt-out” screening (CDC, 2006).  The CDC recommends screening all 
patients at least once; however, patients who are considered high-risk, such as intravenous drug 
users, men who have sex with men, an individual who has a sexual partner that is HIV-positive, 
someone that exchanges sex for goods, or an individual who is heterosexual with multiple sexual 
partners, should be screened at least annually (CDC, 2006).  The CDC recommendations for 
routine HIV screening are included in the most recent update to the 2015 CDC STD evidence-
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based guidelines to try to enhance the likelihood that HIV screening is being conducted during 
STD testing visits (CDC, 2015). 
The United States Preventive Services Task Force Recommendation for Routine HIV 
Screening 
 In 2013, the USPSTF revised their recommendations for routine HIV screening that 
includes screening all patients ages 15 to 65 years old as well as screening patients older than 65 
years old or younger than 13 years old who are at risk for HIV infection (Figure 1).  The 
screening is voluntary similar to the CDC recommendations and patients can opt-out of 
screening once the provider has offered the screening.  The USPSTF recommendations state 
there is insufficient evidence to recommend testing intervals for patients; however, patients at a 
higher risk for becoming infected with HIV should be offered screening at least annually 
(USPSTF, 2013).  The USPSTF has assigned a grade of “A” to this recommendation, meaning 
this service should be offered or provided by health care providers (USPSTF, 2013).  For the 
purpose of this DNP project, the 2013 USPSTF guidelines were utilized for screening patients at 
the primary care clinic located in Guilford County that participated in the project. 
 





 One in seven individuals are unaware of their HIV diagnosis and therefore experience a 
delay in HIV care (CDC, 2017a; Dailey et al., 2017).  People who are aware of their HIV status 
can reduce behaviors to decrease HIV transmission to others, be linked into HIV care and begin 




The USPSTF recommends that clinicians screen for HIV 
infection in adolescents and adults aged 15 to 65 years. 
Younger adolescents and older adults who are at increased risk 
should also be screened. 
A 
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antiretroviral medications to achieve viral suppression (Dailey et al., 2017).  As viral suppression 
is achieved through antiretroviral therapy, an individual’s immune system can be preserved, 
decreasing the risk of morbidity and mortality and also reduces HIV transmission to others 
(Dailey et al., 2017). 
 The CDC’s Division of HIV/AIDS Prevention Strategic Plan for 2017 to 2020 outlines 
four main goals for HIV prevention (Table 2). 
 
Table 2. The CDC’s Division of HIV/AIDS Prevention Strategic Plan for 2017 to 2020 (CDC, 
2017c). 
Division of HIV/AIDS Prevention Strategic Plan 2017-2020 
Goals Objectives 
Prevent New HIV 
Infections 
1.  Increase the percentage of persons living with HIV who 
know their serostatus to at least 90%. 
2. Increase the number of persons who are using PrEP by 
500%. 
Improve Health 
Outcomes for Persons 
Living with HIV 
1. Increase the percentage of persons with diagnosed HIV who 
are linked to care within one month of diagnosis. 
2. Increase the proportion of PLWH with sustained viral 
suppression. 
Reduce HIV-related 
Disparities and Health 
Inequities 
1.  Reduce disparities in the rate of diagnoses among (1) gay, 
bisexual men; (2) young black gay and bisexual men; (3) black 
women; and (4) persons living in the South. 
2.  Increase the percentage of youth and persons who inject 
drugs who are virally suppressed. 
3.  Reduce stigma and discrimination associated with the 
acquisition and transmission of HIV. 
Continually Improve 
Effectiveness and 
Efficiency of Operations 
1. Recruit and retain a highly qualified, satisfied, and motivated 
workforce. 
2.  Ensure effective use of intramural and extramural resources 
through robust resource and program management. 
3.  Maximize the efficiency of administrative processes. 
 
 The first goal to prevent new HIV infections was the focus of this DNP project.  
Screening is an important part of prevention – secondary prevention- to know one’s status to get 
into early treatment to decrease the viral load and transmission to others.  A main objective of 
this prevention goal is to have at least 90 percent of individuals living with HIV to know their 
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serostatus by the year 2020 (CDC, 2017c).  To meet this goal of the Strategic Plan, increasing 
provider adherence to the 2006 CDC HIV screening recommendations is advised as well as 
increasing the awareness of HIV, reducing HIV-related stigma and promoting HIV screening 
(CDC, 2017c).  In 2015, the U.S. National HIV/AIDS Initiative established a five-year plan with 
similar goals to the CDC’s Strategic Plan to include reducing new HIV infections and increasing 
the percentage of people living with HIV who know their status to at least 90 percent (Kahn & 
Nicosia, 2017). 
 The purpose of this DNP project was to increase routine HIV screening in a primary care 
practice in Guilford County, North Carolina using evidence-based interventions and the 2013 
USPSTF HIV screening recommendations.  The review of the literature and the framework of 
the Chronic Care Model guided this project. 
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CHAPTER 2: REVIEW OF LITERATURE 
Review of the Literature: Interventions for Improving Routine HIV Screening 
This review of the literature will summarize the most up-to-date evidence-based 
interventions to increase screening for HIV in various primary care settings.  The emphasis was 
on strategies that work to increase screenings using the recommendations from the USPSTF and 
the CDC.  The purpose of the review of literature was to determine the most feasible and 
acceptable methods providers can use to routinely screen patients for HIV in a primary care 
setting. 
Description of Literature Search for Evidence-Based HIV Screening Interventions 
 A literature search was performed for evidence-based HIV screening interventions after 
consulting with the school’s librarian on 10/31/2017.  The Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), PsycInfo, Embase and PubMed databases were searched 
using major search terms “HIV” AND screen* OR test* AND “primary care.”  Searches were 
limited to English language articles and articles with a publication date from 2006 to 2017.  The 
search had a yield of 506 results between the four databases before inclusion and exclusion 
criteria were applied, and a total of 14 articles were retained after duplicates.  The inclusion 
criteria for the literature review were articles published from 2006 to 2017 that discussed HIV 
screening in primary care settings in patients ages 13 to 64 years old or 15 to 65 years old, based 
on the CDC and USPSTF recommendations.   Exclusion criteria for the literature review 
includes studies conducted with participants who are pregnant, children 12 years old and 
younger, inpatient or hospital settings, HIV clinics, and HIV positive patients at the time of 
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recruitment and infants.  Between the four databases, most articles were duplicated or were 
articles about HIV positive patients or HIV clinics.  For the purpose of the literature review, only 
those articles that discussed routine HIV screening or testing in a primary care setting were 
utilized; therefore, a significant number of articles found were excluded, leaving only 14 articles 
to be used in the review of literature  
The Evidence for Improving HIV Screening 
 Three major themes for improving HIV screening emerged from the review of literature.  
There are several strategies that have been used in studies over the years since routine HIV 
screening recommendations were published to improve screening in primary care settings.  
These strategies include; the use of rapid HIV testing, electronic medical record interventions, 
and staff-initiated HIV screening (Avery, Del Toro, Caron, 2014; Harmon, Collins-Ogle, 
Bartlett, Thompson, Barroso, 2014; Knapp, Anaya, Feld, Hoang, Goetz, 2011). 
Rapid HIV Testing 
 Rapid HIV testing for HIV has led to an increase in HIV screening rates among primary 
care settings in not only the U.S., but in the United Kingdom (U.K.) (Harmon et al., 2014; Leber 
et al., 2015; Schwandt et al., 2012; Valenti et al., 2012).  Rapid HIV testing uses a finger-stick 
sample that can be used to obtain results in about 20 to 30 minutes and is initiated by a trained 
staff member of the clinic, usually a nurse or medical assistant, with results available to deliver 
to the patient during the clinic visit with the provider (Harmon et al., 2014; Leber et al., 2015; 
Schwandt et al., 2012; Valenti et al., 2012).  The use of rapid HIV screening has been found to 
be favorable among patients and providers, allowing more patients to be screened and prevent 
the patient from having to return to the clinic to obtain the results (Harmon et al., 2014; Leber et 
al., 2015; Schwandt et al., 2012; Valenti et al., 2012). 
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 One of the barriers found to rapid HIV testing was related to time (Harmon et al., 2014; 
Valenti et al., 2012).  Decreased rates of testing were noted if the clinic was short-staffed or busy 
(Harmon et al., 2014; Valenti et al., 2012).  Most often providers are seeing patients every 15 
minutes and having to discuss a positive HIV result will take longer than a 15-minute visit 
(Harmon et al., 2014; Valenti et al., 2012).  But, rapid testing is found to be positive in terms of 
the patient’s perspective.  Patients reported time constraints as barriers to accept tradition HIV 
screening through venipuncture and would not return for results if they had to wait several days 
for results (Harmon et al., 2014; Schwandt et al., 2012; Valenti et al., 2012). 
 In some cases, primary care clinics had seen a large percentage of patients screened for 
HIV using rapid testing and others did not despite the intervention of rapid testing.  In 2015, a 
cluster-randomized controlled trial in the U.K. used rapid point-of-care testing for HIV as a 
modality to improve HIV screening rates in primary care (Leber et al., 2015).  This study had 
45% acceptance rate of patients who were offered screening for HIV (Leber et al., 2015).  A 
seven-week study offering rapid screening at routine office visits to 138 patients had 72% 
acceptance rate (Harmon et al., 2014).  In another study, only six percent of patients seen were 
screened for HIV; however, of the 6,125 patient visits used during the intervention period, only 
536 patients were offered HIV screening with 367 accepting the screening (Valenti et al., 2012). 
 Rapid HIV screening can be useful; however, providers are hesitant to initiate rapid 
testing because of not being guaranteed reimbursement (Valenti et al., 2012).  Only one of the 
four studies that was a randomized-controlled trial showed the highest quality of evidence using 
rapid HIV testing; however, it was not conducted in the U.S. and did not use the CDC or 
USPSTF recommendations for screening (Leber et al., 2015).  The site where this DNP project 
took place at does not offer rapid HIV testing because of time constraints, cost for 
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reimbursement and the availability of laboratory testing that is more specific and sensitive that 
can be covered by insurance.  
Electronic Medical Record Interventions 
 The use of an electronic medical record reminder has been used in several studies for 
improving screening rates for HIV in primary care (Avery, Del Toro, Caron, 2014; Marcelin et 
al., 2015; Rodriguez et al., 2016).  Besides using an electronic medical reminder, other 
interventions to improve screening included: providing education about the screening 
recommendations to providers, facilitating a discussion on local epidemiology and the benefits of 
early detection, and access to treatment for positive results (Avery et al., 2014; Marcelin et al., 
2015; Rodriguez et al., 2016) 
 In 2010 at a large Ohio hospital, an electronic medical reminder was added to the 
electronic medical record that passively reminded providers to screen patients once for HIV and 
then mark the task completed (Avery et al., 2014).  However, a disadvantage discussed in this 
study was that providers often ignored the reminder in the patient’s electronic medical record 
leaving patients not tested for HIV at the clinic (Avery et al., 2014).  The intervention was 
evaluated by control chart methodology that looked for trends in screening and non-screening, 
finding an increase in the number of patients who received screening for HIV (Avery et al., 
2014).  This study also identified 33 new cases of HIV during the intervention period from 2010 
to 2011 (Avery et al., 2014). 
 A clinical decision support (CDS) tool was used at a primary care practice in Minnesota, 
which worked similarly to other studies; however, this was developed from the Generic Disease 
Management System (GDMS) (Marcelin et al., 2016).  The CDS tool is frequently used to 
manage chronic diseases, medications and diagnoses, and delivers alerts to providers when 
certain tasks are due (Marcelin et al., 2016).  In a four-month period after the implementation 
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period, 218 individuals were screened for HIV after the CDS tool was implemented versus the 
109 screened prior to the start of the intervention (Marcelin et al., 2016).   
 The electronic medical record in a community health center network was modified in 
2011 to have a prompt with a specific script read by the medical assistant to offer the HIV 
screening (Rodriguez et al. (2016).  This study implemented in the Bronx and Queens in New 
York, was shown to increase testing rates from 61% of 76,649 in 2011 to 89% of 100, 369 tested 
in 2013, which resulted in 166 new HIV diagnoses between 2011 and 2013 (Rodriguez et al., 
2016).  The prompt discussed in the study denotes it as a clinical decision support alert, but it 
does not provide additional information about the prompt with exception that it complies with 
HIV testing laws of the State of New York (Rodriguez et al., 2016). 
 One study used the electronic medical record in a different way than the other studies and 
was shown to be effective at increasing the rate of individuals who were tested for HIV (Golden 
et al., 2017).  The electronic medical record was used to identify the patients with upcoming 
appointments at the clinic in the State of Washington to determine if they had ever had an HIV 
test with the specific laboratory affiliated with the clinics used in the study.  The list of patients 
that needed an HIV screening were given to a staff member that was designated to work on the 
study, while medical assistants entered the pre-orders for testing for eligible patients (Golden et 
al. 2017).  This method of using the electronic medical record increased HIV screening from 
14.9% to 30.8% (P<0.0001) over the four-year period of the intervention (Golden et al., 2017). 
 The utilization of the electronic medical record does show slight improvement in 
screening practices for HIV (Avery et al., 2014; Marcelin et al., 2015; Rodriguez et al., 2016).  
However, higher-quality studies are needed to make further improvements for the way screening 
practices should take place utilizing the electronic medical record.  The DNP project site utilizes 
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the Epic Systems software for their electronic health record and the software has a reminder 
embedded into the patient’s health maintenance list.  For the remainder of this paper, the word 
Epic will be used when discussing Epic Systems software. 
Staff-Initiated HIV Screening 
 Four identified published studies discuss the initiation of HIV screening by a nurse or 
certified medical assistant in a primary care setting (Anaya et al., 2008; Anim et al., 2013; 
Kinsler et al., 2013; Knapp et al., 2011).  The nurse or medical assistant is designated as the 
champion or the lead for initiating the discussion with the patient about HIV screening at the 
visit, and will prepare to test the patient whether it is through venipuncture or rapid testing 
(Anaya et al., 2008; Anim et al., 2013; Kinsler et al., 2013; Knapp et al., 2011). 
 One study used rapid testing along with promotional brochures and displays to promote 
HIV testing in patients at one Veterans Affairs (VA) outpatient clinic (Knapp et al., 2011).  From 
year one to year two after the intervention, nurse-initiated testing was associated with a 70% 
increase in screening (Knapp et al., 2011).  In another study at a different VA outpatient clinic in 
Los Angeles, nurse-initiated and physician-initiated testing were compared to one another which 
showed that 55% of tests were offered by a nurse and 45% by a physician (Kinsler et al., 2013) 
 A two-site, three arm randomized controlled trial was developed evaluating nurse-
initiated HIV screening versus traditional screening in three VA clinics in Southern California 
(Anaya et al., 2008).  Data results were from two different sources, the EMR, and patient-based 
surveys regarding the reason for HIV screening, how they want to receive the results, how to 
reduce the risk of transmission and how to improve HIV knowledge (Anaya et al., 2008).  The 
three models for HIV screening are; Model A: traditional HIV counseling and testing; Model B: 
nurse-initiated screening and traditional counseling and testing; Model C: nurse-initiated 
screening with streamlined counseling and rapid testing.  Model C was the most effective with an 
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89.3% rate for testing for HIV.  Model B had the second highest rate for HIV testing with 84.5%.  
The use of Model C being more favorable for HIV screening relates back to rapid testing because 
patients prefer to have rapid testing that is initiated by nursing staff to get results at the same visit 
without the inconvenience of having to return to the clinic (Anaya et al., 2008). 
 The final study used a medical assistant to offer HIV screening to all patients as they 
entered the clinic over a three-month period (Anim et al., 2013).  Patients had to pay out of 
pocket for testing, which led to only 17% of the patients accepted screening for HIV (Anim et 
al., 2013).  However, rates previously for HIV screening were less than 1%; so, 17% is a 
significant increase at this practice even with patients having to pay out of pocket for testing 
(Anim et al., 2013). 
Summary of the Literature Search 
There were several studies that shared a connection between staff-initiated and rapid 
screening as ways to improve HIV screening rates.  Even with the use of electronic medical 
record reminders, screenings were missed or ignored by staff and providers (Avery et al., 2014).  
As more primary care settings begin to implement routine HIV screening, there is the potential 
for higher-quality studies to be conducted.  Further research is needed into screening practices 
for HIV to understand the role that electronic medical record reminders, rapid-testing and staff-
initiated screenings play in improving screening rates and increasing the number of people who 
know their HIV status.  From the literature, one of the most effective ways for providers to 
increase HIV screening rates in primary care is to integrate rapid testing at the beginning of the 
visit, that is initiated by a nurse or medical assistant after viewing a prompt in the electronic 
medical record to offer the HIV screening.  The practice site where this DNP project takes placed   
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does not currently do rapid HIV testing because of time constraints, cost and lack of 
reimbursement from third party payers.  Most insurance carriers will cover the fourth generation 
HIV antibody serum laboratory test ordered by providers. 
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CHAPTER 3: THEORETICAL FRAMEWORK 
The Chronic Care Model 
 The plan for this DNP project was to design and implement a performance improvement 
project to increase routine HIV screening in a primary care setting.  The Chronic Care Model 
(CCM) was used as the framework to guide the design and implementation of the DNP project.  
The CCM is an evidence-based and team-based approach to deliver high quality care that is 
patient-centered to manage chronic diseases to improve health outcomes (Coleman, Austin, 
Brach, Wagner, 2009; Group Health Research Initiative, 2018; Pasricha, Deinstadt, Moher, 
Killoran, Rourke, Kendall, 2012; Tu, Belda, Littlejohn, Somlak-Pederson, Valle-Rivera, Tyndall, 
2013; Wagner, Austin, Davis, Hindmarsh, Schaefer, Bonomi, 2001).  Previously, the CCM has 
been used in chronic diseases such as hypertension, diabetes mellitus, congestive heart failure 
and chronic obstructive pulmonary disease (Group Health Research Initiative, 2018; Pasricha et 
al., 2012; Tu et al., 2013; Wagner et al., 2001).  More recently, the CCM has been used for 
improving care among patients who are HIV-positive as well as patients who are HIV-negative 
for increasing the number of people screened for HIV (Goetz, Bowman, Hoang, Anaya, Osborn, 
Gifford, Asch, 2008; Tu, et al., 2013).   
 The CCM is made up of six components for delivering disease care: the health system, 
decision support, delivery system design, clinical information system, self-management support, 
and the community (Coleman et al., 2009; Goetz et al., 2008; Group Health Research Initiative, 
2018, Pasricha et al., 2012; Tu et al., 2013; Wagner et al., 2001).  This DNP project used all six 
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of the components to guide the practice change and improve patient outcomes related to HIV 
screening (Table 3). 
 
Table 3. The Six Components of the Chronic Care Model Utilized in this DNP Project. 
The Health 
System 
Engaged stakeholders in the practice setting and identified practice champions 
to support this DNP project to improve routine HIV screening. 
Decision 
Support 
Educated staff and providers on HIV screening recommendations, evidence-
based practices to increase screening and increasing their knowledge of the 
link to the USPSTF (2013) recommendations as well as the electronic medical 




Supported team-based practice for staff and providers to offer HIV screening 
to patients using the USPSTF (2013) recommendations during routine visits, 




Utilized an integrated electronic medical record (EMR) reminder into the 
health maintenance list in the EMR for each patient.  Collected monthly 
reports for data on HIV screening based on the Epic code PROC_CODE 




Providers and staff offered HIV information to patients on screening; 
supported shared-decision making allowing patients to make informed 
decisions to accept or decline screening at the practice site.  Informed patients 
of other HIV testing options in the community. 
The 
Community 
Introduced community resources to providers and staff around options for free 




The Six Components of the Chronic Care Model 
The Health System 
In this component, the health system is considered as an organization that thrives on a 
culture of patient safety and the delivery of high-quality care (Coleman et al., 2009; Group 
Health Research Initiative, 2018, Tu et al., 2013; Wagner et al., 2001).  The leadership in the 
organization must be supportive of practice changes and delivery methods by utilizing quality 
improvement teams to set goals to improve patient care and prevent errors and mistakes 
(Coleman et al., 2009; Group Health Research Initiative, 2018, Tu et al., 2013; Wagner et al., 
2001).  In this project, engaging the stakeholders and identifying the practice champions to allow 
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this process improvement project to take place in the clinic and increase routine HIV screening 
applied the concept of the health system. 
Decision Support 
The decision support component of the model promotes the use of evidence-based 
practices by health care providers to improve care (Coleman et al., 2009; Goetz et al., 2008; 
Group Health Research Initiative, 2018; Pasricha et al., 2012; Tu et al., 2013; Wagner et al., 
2001).  The use of clinical practice guidelines and recommendations should be discussed with 
patients for them to gain a better understanding of recommended treatment modalities.  As health 
care evolves, new guidelines and recommendations are being published or updated and health 
care providers will need to adopt new practices.  When facilitating a practice change, several 
support systems can be integrated to promote change such as reminders, distributing educational 
materials, using case studies, or using audit and feedback (Coleman et al., 2009; Goetz et al., 
2008; Group Health Research Initiative, 2018; Pasricha et al., 2012; Tu et al., 2013; Wagner et 
al., 2001).  In the context of this project, the decision support component was applied through 
increasing the knowledge of the national HIV screening guidelines for all staff and providers of 
the clinic and using the link to the screening recommendations along with the electronic 
reminder in the health maintenance section in the electronic medical record. 
Delivery System Design  
The delivery system design is a component of the CCM that promotes health prevention 
and thrives on a team-based approach.  These components of the CCM involves staff being 
assigned to specific roles for tasks to be completed and are involved in promoting the delivery of 
evidence-based care (Coleman et al., 2009; Goetz et al., 2008; Group Health Research Initiative, 
2018; Tu et al., 2013; Wagner et al., 2001).  For a change in practice to occur, the staff and 
providers must be aware of each other’s roles in this process improvement.  Staff in the clinic 
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needed to expand on their role in the practice to include the discussion of the HIV screening to 
aid in improving screening rates.  According to the literature, using certified medical assistants or 
nurses as the first staff members to offer screening to patients was shown to be effective at 
improving screening rates (Anaya et al., 2008; Anim et al., 2013; Kinsler et al., 2013; Knapp et 
al., 2011).  Other clinic staff such as receptionists and schedulers, were also educated on the 
screening recommendations for routine HIV screening and could discuss with patients why the 
clinic is promoting routine HIV screening and the importance of patients knowing their HIV 
status.  Support for the delivery system design component for this project was through team-
based practice using the staff and providers to offer HIV screening to patients using the USPSTF 
(2013) recommendations during routine visits, annual examinations or STD or STI screening 
visits. 
Clinical Information Systems 
The clinical information systems (CIS) component of the CCM is used for organizing 
patient data for facilitating and improving quality patient-centered care which can be done 
through the electronic medical record using clinical reminders and audit and feedback reports 
(Coleman et al., 2009; Goetz et al., 2008; Group Health Research Initiative, 2018; Pasricha et al., 
2012; Tu et al., 2013; Wagner et al., 2001).  This component of the CCM was used in the DNP 
project by utilizing an electronic medical reminder already integrated in the health maintenance 
list in each patient’s electronic medical record.  When using an electronic medical reminder, 
patient data can be tracked and linked to testing to determine who has had the screening, and can 
be used to determine those patients who had not been screened previously.  Reports were 
collected after the end of the intervention at the project site for data on HIV screening based on 
the code from Epic - PROC_CODE LAB 3107 and the ICD-10 codes for office visits for 
physicals and STD or STI examinations. 
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Self-Management Support 
The self-management support component of the CCM identifies the critical role patient’s 
play in managing their own care (Coleman et al., 2009; Group Health Research Initiative, 2018; 
Tu et al., 2013; Wagner et al., 2001).  This component emphasizes patient making their health 
care decisions based on the knowledge received from providers and perhaps conducting their 
own research (Coleman et al., 2009; Group Health Research Initiative, 2018; Tu et al., 2013; 
Wagner et al., 2001).  The self-management support component was applied to this project 
through the providers offering HIV screening to their patients, allowing them to make their own 
decision about accepting the screening or not.  When offering HIV screening, the providers and 
staff were expected to educate patients on the screening recommendations, but again allowing 
the patient to make their own decision in regards to the screening.  For patients who refuse to be 
screened at the clinic, the providers or clinic staff were educated to advise the patient to utilize 
other options of various community resources that offer confidential and free HIV screening.  
Handouts, flyers and posters were given to the providers and staff to display throughout the 
clinic in waiting areas and clinic rooms to provide further information on routine HIV screening 
to patients who are waiting to be seen and to begin the process of contemplating accepting or 
declining to be screened for HIV (Appendix 2). 
The Community 
The community component is the final component of the CCM and involves utilizing the 
resources within the community to foster partnerships to meet the patient’s needs and assist with 
self-management support (Coleman et al., 2009; Group Health Research Initiative, 2018; Tu et 
al., 2013; Wagner et al., 2001).  Community programs can assist patients with the resources 
needed to cope with chronic diseases and promote self-care (Tu et al., 2013; Wagner et al., 
2001).  Patients that do not wish to be screened for HIV may do so at other community-based 
   
22 
settings.  This final component was applied to the project by introducing the providers to the 
various community resources for HIV care and support.  Through these organizations, the 
providers can work to establish professional relationships to facilitate referrals for patients who 
are HIV-positive or for patients who are at a high-risk for HIV infection to receive additional 
services or even initiate the pre-exposure prophylaxis medication.  Handouts, flyers and posters 
were given to the providers and staff to display throughout the clinic in waiting areas and clinic 
rooms to provide further information on routine HIV screening to patients who are waiting to be 
seen (Appendix 2). 
Summary of the Chronic Care Model 
 The CCM was utilized to assist the providers and staff through the practice change to 
increase routine HIV screening in their clinic to improve both patient outcomes as well as 
outcomes within the health system.  The prevention, screening and treatment of HIV can be well 
managed when both the patient and the providers take a proactive step to improving health care. 
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CHAPTER 4: PURPOSE STATEMENT 
Purpose 
The purpose of this DNP was to increase routine HIV screening in a primary care 
practice in Guilford County, North Carolina using evidence-based interventions and the 2013 
USPSTF HIV screening recommendations.   
 The goals of the DNP project were to: 
1. Increase the percentage of HIV screenings offered to patient’s ages 15 to 65 years 
old following the evidence-based USPSTF (2013) recommendations as a guide 
for screening. 
2. Engage stakeholders of the practice and identify practice champions to support 
this DNP project to improve routine HIV screening.  
3. Understand provider and staff personal perspectives about routine HIV screening 
at the practice site before and after the intervention using a validated pre- and 
post- intervention survey (Appendix 4).  
4. Inform health care providers and clinic staff at the DNP project site on the routine 
HIV screening guidelines, HIV prevalence and incidence in Guilford County, 
North Carolina and the critical need to screen. 
5. Identify barriers and process improvements for routine HIV screening using focus 
groups and semi-structured interviews monthly with clinic staff and providers 
during the intervention period. 
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6. Implement evidence-based interventions to improve routine HIV screening such 
as utilizing an electronic medical record (EMR) reminder, training on CPT code 
87389 and ICD-10 codes of office visits for physicals and STD or STI exams, and 
taking a team-based, patient-centered care approach for shared-decision making. 
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CHAPTER 5: METHODOLOGY  
Context 
 The following text describes the primary care clinic setting where this process 
improvement project took place.  The intervention period was from September 1, 2018 to 
November 30, 2018. 
 The DNP project timeline is as follows according to Table 4. 
 
Table 4. The DNP Project Timeline from 2018 to 2019. 
DNP Project Timeline 
April 2018 DNP Project Proposal Defense. 
May 2018 Submitted application to Institutional Review Board (IRB). 
July 2018 Received IRB approval from the University of North Carolina at Chapel 
Hill. 
August 2018 Received Nursing Research Council and IRB approval from Cone 
Health. 
Completed first information session with providers and distributed pre-
intervention surveys at project site. 
September 2018 Data collection period began; completed information session with clinical 
staff and distributed surveys. 
October 2018 Completed information session with front-desk staff and distributed 
surveys.  
November 2018 Final month for data collection; provided education to staff on World 
AIDS Day. 
December 2018 Received results of data from 2018 and 2017. 
January and 
February 2019 
Completed follow up surveys with providers and clinic staff. 
 
Design 
 This DNP project was a performance improvement project aimed to increase routine HIV 
screening in a primary care practice in Guilford County, North Carolina using evidence-based 
interventions and the 2013 USPSTF HIV screening recommendations.  All staff and health care 
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providers were involved in the project and were educated on offering the screening to patient’s 
ages 15 to 65 years old, following the 2013 USPSTF recommendations during the three-month 
intervention period.  The DNP project intervention period was from September 1, 2018 to 
November 30, 2018 and was compared to the number of HIV screenings previously completed at 
the practice during the same three-month time period, the year before the intervention from 
September 1, 2017 to November 30, 2017.  
Setting 
The setting for this DNP project was at an internal medicine primary care clinic located 
in Guilford County, North Carolina.  The clinic sees approximately 120 to 130 patients per day.  
The providers have approximately 2,000 patients assigned to them.  The sex of the patient 
population consists of approximately 55.5% females and 45.5% males.  The average age of the 
patient population is between 55 to 60 years old.  The race of the patient population is comprised 
of approximately 60% White or Caucasian, 30% Black or African American, 3.0% other or two 
or more races, 2.0% Asian, 3.0% declined to answer or is unknown, and 1.0% American Indian 
or Alaska Native. 
An estimated 60% of the patients who come to the clinic have Medicare, whether that is a 
traditional or an Advantage plan and the other 40% is patients with commercial insurance.  The 
clinic does not accept Medicaid as a primary insurance, however, according to the practice 
manager, many of the patients who have Medicare also have Medicaid as a secondary insurance 
carrier.  
This site was selected for this project because of the location of the practice being in an 
area where a higher number of patients living with HIV reside and the high incidence for new 
cases of HIV infection.  This location is easily accessible by car or public transportation as well.   
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Population 
The population that was the focus of this DNP project included the health care 
professionals and staff members that offer and encourage patients ages 15 to 65 years old to be 
screened for HIV at the practice site during routine visits, annual physical examinations, or STD 
or STI screening visits.  As of February 2019, the practice consists of seven providers, which 
include one nurse practitioner and six physicians who provide primary care services to patients in 
Guilford County. 
Interventions 
 This was a process improvement project using evidence-based HIV screening 
recommendations, provider and staff education and an electronic medical record reminder to 
create a practice change to increase routine HIV screening in a primary care setting.  The 
Chronic Care Model has been used as a guide for this DNP project (Table 3). 
Use of the United States Preventive Services Task Force 2013 Final Recommendation 
For the purposes of this DNP project, the USPSTF 2013 recommendation for HIV 
screening was referenced (Table 1), and included patients ages 15 to 65 years old based on this 
Grade A recommendation; who presented to the clinic for a routine physical, an annual visit or 
presented for STD or STI screening.  Currently, there are not clear recommendations as to how 
often to screen for HIV, except for patients who are considered high-risk or are pregnant and do 
not know their HIV status.  Those patients “should be screened more often” (USPSTF, 2013).  
This also includes patients fewer than 15 years old or over 65 years old who are categorized as 
high-risk (USPSTF, 2013).  The USPSTF recommendations indicate that patients considered to 
be at high-risk, including men having sex with men (MSM), people who have an STD or STI, 
and a person using intravenous drugs, should be screened more frequently or at least annually for 
HIV to prevent disease transmission or early detection of HIV (USPSTF, 2013).  Other patients 
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who may be at risk for HIV infection include those who have unprotected sex with multiple 
partners, or do not know their partner(s) HIV status. 
 There is not a specific HIV test that has been recommended by the USPSTF; but for the 
purposes of this DNP project, the project site used the Food and Drug Administration (FDA) 
approved fourth generation HIV-1 and HIV-2 antigen/antibody combination test via 
venipuncture by a qualified phlebotomist employed by Quest Diagnostics.  Since the passing of 
the Affordable Care Act, Medicaid, Medicare and most private insurances are required to cover 
“A” and “B” grades from the USPSTF (The AIDS Institute, 2016).  The practice site does not 
currently do any rapid HIV testing because of time constraints, cost and lack of reimbursement 
from third party payers.  
Information Sessions 
There were several information sessions throughout the intervention period, with the first 
session used as a launch of this DNP project.  The first information sessions was in August 2018, 
given as a lunch and learn for the health care providers, the lead registered nurse of the practice 
and the practice manager.  There were seven providers present, including two nurse practitioners 
and five physicians.  During this time, the participants at the information session completed a 
pre-intervention survey (Appendix 4) and were given handouts on various community resources 
for HIV, information on routine HIV screening recommendations from the USPSTF and basic 
HIV statistics. They were also given HIV screening posters and brochures from the CDC to 
display around the office.  Providers were able to give feedback and participated in discussion 
about their HIV screening practices.  Also discussed during this time was the EMR reminder for 
HIV screening already embedded into Epic, along with diagnosis codes and lab CPT billing code 
to use for HIV screening (Appendix 2).  During this meeting, it was also mentioned what the 
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literature stated about using CMAs and nurses to help initiate the discussion for screening before 
the provider came into the exam room. 
 In September 2018, a second information session was held at a staff meeting for clinical 
staff.  There were 10 participants that were a mix of certified medical assistants and registered 
nurses.  The participants completed the pre-intervention survey and were provided information 
on the 2013 USPSTF routine HIV screening recommendations as well as basic statistics on HIV.  
There was discussion about the HIV screening reminder in the EMR that is accessible to nurses 
and the certified medical assistants.  Also discussed was what the literature had mentioned about 
improving screening rates for HIV by having the CMA or nurse offer the screening prior to the 
provider coming into the room.  This process was not being done at the clinic prior to project 
starting.  During this month, one of the providers, who returned from maternity leave, was given 
the survey to complete and given the HIV screening education materials that were given at the 
provider information session in August 2018 (Appendix 2 & 4).  
 In October 2018, a third information session was held for the front-desk staff.  Seven 
participants completed a pre-intervention survey and were educated on basic HIV statistics, the 
routine HIV screening recommendations, and the EMR reminder already available in the medical 
record.  During this month, a new nurse practitioner to the practice was educated on routine HIV 
screening and completed a survey.  This new nurse practitioner was also given the same 
education materials that were given to providers at the beginning of the project in August. 
 In January 2019, the providers and clinic staff were given the post-intervention survey 
and educated on the draft USPSTF recommendations for screening and the updated statistics for 
N.C. and Guilford County (Appendix 9).  There was time for discussion and questions. 
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Focus Groups and Semi-Structured Interviews 
Throughout the intervention period, the DNP project lead visited the clinic several times 
each month of the intervention to talk with different staff members about HIV screening in the 
practice and discuss if there were any barriers to screening that have been discovered since 
starting the project.  Updates on the project as well as new HIV statistics were discussed during 
these meetings.  Also discussed were suggestions on the way the clinic can improve routine HIV 
screening. 
Electronic Medical Record  
The EMR used at the project site is Epic.  The health system that is affiliated with the 
practice site already has embedded HIV screening in the health maintenance section of the 
medical record to remind providers to offer screening to patients.  The HIV screening 
recommendations from the USPSTF published in 2013 are used for this health system for routine 
HIV screening, however; since the recommendations for how often to screen are ambiguous at 
this time, the reminder only asks for screening to be done once between the ages of 15 to 65 
years old.  All patients who are between the ages of 15 to 65 years old either have a documented 
HIV test result or have an “overdue” message under the health maintenance section if HIV 
screening has not been done or documented.  Providers were encouraged to modify the patient’s 
health maintenance record to remind them to offer screening every year if the patient declined 
screening that year or to remind them to offer again if they are a high-risk patient.  If a patient is 
overdue for a health maintenance item, the patient banner on the EMR is highlighted in red to 
grab the attention of the provider or staff member reviewing the health maintenance items.   
 Once the HIV screening has been completed, a hyperlink to the date of the test completed 
is available, and when clicked on, shows the result of the HIV test completed.  At this time, 
providers cannot order an HIV test through health maintenance, but once a test is ordered and 
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completed, the hyperlink is available to view the result.  The health maintenance items are 
updated nightly automatically after the clinic is closed.  The providers, CMAs and RNs were 
instructed to check for HIV screening completion under health maintenance for patients 
presenting for physicals, annual exams, and STD or STI screening visits to verify that these 
patients were screened for HIV.  
Measures 
Survey 
The provider survey (Appendix 4) used in the project to survey health care providers and 
staff was developed by the CDC using a review of literature as well as thorough discussions and 
presentations from various health care providers regarding HIV screening and is included in their 
evaluation toolkit for routine HIV screening (CDC, 2012).  The CDC has tested the validity of 
the survey with nine providers at a public clinic; and it has been reviewed by a variety of health 
care providers in various clinical settings (CDC, 2012).  The CDC has made the survey available 
to the general public and can be easily reproducible without requiring additional permission to 
use or modify.  The survey was easily modified to fit the practice setting where the project took 
place and can be modified to fit most health care settings where routine HIV screening is to be 
implemented. 
 The survey has a total of 26 questions divided between four sections that take 
approximately 10 to 15 minutes to complete (Appendix 4).  Section A asks two questions 
regarding the participant’s professional role and their role in HIV screening.  Section B has 11 
questions that pertain to participants’ personal perspectives related to routine HIV screening in 
their current practice setting.  Section B’s questions are rated on a five-point Likert scale, 1 = 
strongly disagree, 2 = disagree, 3 = neither agree or disagree, 4 = agree, 5 = strongly agree; 
and additional responses include; don’t know and not applicable.  Section C questions pertain to 
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participant perspectives on routine HIV screening in their practices, asking seven questions using 
a different five-point Likert scale than section A.  The section C Likert scale is rated as follows, 
1 = never, 2 = rarely, 3 = about half the time, 4 = most of the time, 5 = almost always or always.  
Additional responses in section C include don’t know and not applicable.  Section D (Appendix 
5) includes three open-ended short answer questions for participants to describe the benefits and 
positive outcomes, the problems and negative outcomes, and additional comments about routine 
HIV screening in their setting.  Sections A – C were used for the pre- and post-intervention 
survey, and section D was used in the post-intervention survey only. 
Pre-Intervention Survey 
The health care provider and staff questionnaire developed from the CDC was distributed 
at the beginning of the project to the providers as well as on a rolling basis to staff members and 
new providers that came to the clinic during the project.  Section A through C was utilized in the 
pre-intervention survey only.  Surveys were distributed during lunch and learn meetings and staff 
meetings.  The majority of the providers were given the survey in August 2018, the clinical staff 
in September 2018, and the front-desk staff in October 2018.  There was one provider that was 
on maternity leave during the lunch and learn for providers and was given the survey in 
September upon their return from leave.  A second provider that was new to the practice was 
given a survey in October once he or she started at the clinic. 
 The purpose of the pre-intervention survey was to determine the views of HIV screening 
among staff and providers (participants) at the project site (Appendix 4).  The participants of the 
survey were given dummy identifiers, which were used to compare pre- and post-intervention 
survey results and to maintain confidentiality.  The dummy identifier was a random number that 
was assigned to each survey and used during the pre- and post-survey distribution. 
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 Once the surveys were completed, the answers were entered into Qualtrics software to 
prepare for data analysis.  The dummy identifiers given to the providers were used in the 
Qualtrics software to keep the answers confidential. 
Post-Intervention Survey   
The post-intervention survey (Appendix 4 - 5) was distributed to providers and staff in 
January 2019 during their monthly staff meetings.  The survey that was distributed included the 
same sections as the pre-intervention survey (sections A through C) and included the three open-
ended, short answer questions from section D (Appendix 5).  The survey participants were given 
the same dummy identifier from the pre-intervention survey with the post-intervention survey to 
be used to compare the pre- and post-survey results and maintain confidentiality.  Once the 




The survey responses were synthesized quantitatively into seven topics suggested by the 
CDC from the evaluation toolkit from which this survey is derived from.  Each of the seven 
topics correlated with specific questions from the survey.  The pre- and post-intervention surveys 
are the same questions; however, the post-intervention survey responses differ slightly from the 
pre-intervention survey with the inclusion of the synthesis of the responses to the three open-
ended questions in section D of the survey (Appendix 4).  The dummy identifiers assigned to the 
survey participants were utilized to compare pre- and post-intervention data to look for changes 
in knowledge and attitudes.  The two surveys were compared using t-tests in Qualtrics and SPSS.  
Completed pre- and post-intervention surveys completed were matched using their dummy 
identifiers and analyzed using a dependent t-test.  Along with using t-tests, the survey results 
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were used to look for themes among the clinic staff about their knowledge, attitudes and personal 
perspectives on routine HIV screening. 
Focus Group Responses 
The focus groups and semi-structured interviews were analyzed quantitatively for 
common themes to draw conclusions about routine HIV screening and were compared with the 
themes discovered using the pre-and post- intervention surveys. 
Electronic Medical Record Utilization 
The outcome of the project was for an increase in the percentage of HIV screenings 
offered among patients ages 15 to 65 years old who presented to the clinic for a routine visit, an 
annual physical examination, or STD or STI screening visit.  During the pre-intervention 
information session, the providers and staff were educated on the proper diagnosis codes to use 
as well as the CPT code used by the lab for billing purposes.  Retrospective data were obtained at 
the end of intervention period using all patient encounters and the Epic code for the HIV test 
itself – LAB3107 (Table 6). 
 
Table 5. The List of ICD-10 Codes Used When Ordering a Screening HIV Test at Office Visits. 
List of ICD-10 Codes  
Z11.3 Encounter for screening for infections with a predominantly sexual 
mode of transmission 
Z11.4 Encounter for screening for human immunodeficiency virus 
Z00.00 Encounter for general adult medical exam without abnormal findings 
Z00.01 Encounter for general adult medical examination with abnormal 
findings 
Z01.411 Encounter for gynecological exam (general) (routine) with abnormal 
findings 
Z01.419 Encounter for gynecological exam (general) (routine) without 
abnormal findings 
Z20.2 Contact with and (suspected) exposure to infections with a 
predominantly sexual mode of transmission 
Z20.6 Contact with and (suspected) exposure to human immunodeficiency 
virus [HIV] 
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Table 6. The Epic Systems Software Code Used to Identify the Ordered HIV Test. 
Epic Systems Software Codes for the HIV test 
PROC_CODE 
LAB3107 
HIV Antibody [HIV-1 /HIV-2 antigen/antibody (Fourth Generation) 
Test] (Epic) 
 
Table 7. The Patient Encounters Used for Data Collection. 
Patient Encounters 
2017 2018 
Ancillary Orders Ancillary Orders 
Clinical Support Clinical Support 
Office Visit Office Visit 
Orders Only Orders Only 




The data were used to determine the number of HIV screenings completed each month to 
the correlating patient encounters listed in Table 5.  Additional analysis occurred by comparing 
the patient encounters to the Epic code for ordering the HIV test (Table 6 and Table 7).  Basic 
patient demographics were obtained and included; sex, age, race, and ethnicity, along with the 
Epic codes to further stratify the data collected based on these characteristics to compare 2017 
and 2018 data. 
 Retrospective data were collected to obtain baseline data from the previous year during 
the same time period as the current intervention, from September to November.  This 
information was analyzed to compare the proportion of patients previously screened for HIV 
prior to education on screening recommendations and using the electronic medical reminder to 
the proportion of patients currently screened for HIV using the electronic medical reminder and 
using the screening recommendations.  Bar graphs were utilized to observe the trends in the 
baseline and intervention data, to give providers and staff an easy way to see changes that have 
occurred since the start of the intervention. 
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Data Collection 
The data collection for this DNP project was completed through the Information 
Technology (IT) department’s online portal via the Intranet of the health system associated with 
the practice.  The practice champions assisted with requesting the data and facilitating the 
information to the primary investigator that did not include any patient identifiers to maintain 
strict patient confidentiality. 
Ethical Considerations 
 The online training courses completed by the author of the project through the 
Collaborative Institutional Training Initiative (CITI) are titled ‘Good Clinical Practice-Social and 
Behavioral Research Best Practices for Clinical Research,’ ‘Group 2 Social and Behavioral 
Research-Basic Course,’ and ‘Social and Behavioral Responsible Conduct of Research.’  On July 
12, 2018 this DNP project was reviewed by the Office of Human Research ethics and determined 
this project “does not constitute human subjects research as defined under federal regulations and 
does not require IRB approval (Appendix 6).   On August 21, 2018 this DNP project was also 
reviewed and approved by the NRC at Cone Health and the project was reviewed as exempt from 
the Cone Health IRB (Appendix 7).  The staff and providers were made aware that the DNP 
project is affiliated with the School of Nursing at the University of North Carolina at Chapel Hill 
and that the surveys completed and results disclosed during the intervention do not include any 
identifiers remained confidential. 
 During the period of data analysis and extraction, no patient identifiers were used when 
data were extracted from patient medical records.  A third-party IT group affiliated with 
organization the project site belongs to was utilized to obtain the de-identified patient data 
needed for analysis.  The practice champions were utilized for data extraction so that there were   
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no patient identifiers made available to the DNP project lead.  The de-identified patient data that 
were extracted for the purposes of analysis included: age, sex, race, ethnicity, patient encounters, 
and the Epic procedure for the HIV test itself (Table 6). 
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CHAPTER 6: RESULTS 
The HIV Test Data Collection 
 During this process improvement project, providers and staff were educated on the 
recommendations for routine HIV screening.  Baseline data for the project, collected during the 
months of September, October and November 2017, were compared to the interventional data 
received from September, October, and November 2018.  The interventions in 2018 were 
expected to increase provider and staff knowledge of the recommendations and the use of the 
electronic medical record reminder in the EMR to prompt appropriate screening for HIV.   
The baseline data from 2017 and the post intervention data from 2018 were received in 
December 2018 from the IT department from the health system the project site is affiliated with, 
and were provided as a Microsoft Excel spreadsheet.  There were two workbooks; one for 2017 
and one for 2018.  The data that were provided included a column for the encounter type, the 
date the encounter took place, patient sex, patient age, patient race and ethnicity, and the word 
‘null’ or ‘LAB3107’ to denote whether or not an HIV test was ordered in Epic. 
Clinical Encounters 
 Between September 1st and November 30th, 2017, there were a total of 1661 encounters 
in Epic; and in 2018, between September 1st and November 30th, there were 1755 encounters 
(Figure 1).  This was a 5.66% increase in encounters from 2017 to 2018 during the three months 
used to evaluate the data for this DNP project.  Of the 1661 encounters in 2017, there were 427 
HIV tests ordered.  For the total number of encounters in September, October, and November 
2017; 25.7% of these encounters had an HIV test ordered.  In 2018, out of the 1755 encounters 
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there were 443 HIV tests ordered.  In 2018, 25.2% of all encounters from September, October 
and November had an HIV test ordered. 
 
 
Figure 1. Side by side view of the total number of encounters by month for 2017 and 2018. 
 
The HIV Tests by Month in 2017 
 The data collected for the year 2017 include the months September 1st through November 
30th.  For the month of September, 28.5% of encounters had an HIV test ordered (Figure 4).  
There were a total of 142 tests ordered during September (Figure 2).  In October, 155 HIV tests 
ordered, therefore, 27.0% of encounters had an HIV test ordered (Figure 2 & 4).  During the 
month of November there were 130 HIV tests ordered which translates to approximately 22% of 
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Figure 2. Comparison between each month during the year 2017 for the number of HIV tests 
actually ordered in Epic. 
 
The HIV Tests by Month in 2018 
 The data collected from September 1st to November 30th, 2018 had a total of 443 HIV 
tests ordered.  The number of HIV tests ordered during September, October and November, 
respectively, were 173, 174, and 96 (Figure 3).  More tests were ordered in September and 
October in 2018, with a 45% decrease in HIV tests ordered in November when compared to 
October. 
In September, 32% of patient encounters had an HIV test ordered (Figure 4).  For the 
month of October, 28% of patient encounters had an HIV test ordered (Figure 4).  The month of 
November had the lowest percentage of HIV tests ordered out of the 592 encounters for the 
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Figure 3. Comparison between each month during the intervention period in 2018 for the 




Figure 4. Comparison of the percentage of HIV tests ordered each month during 2017 and 2018. 
 
 
The HIV Tests Ordered by Encounter Type 
 Seven different types of encounters were documented in Epic where providers placed an 
order for an HIV test (Table 7).  It is not known, at this time, whether or not these were 
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is during an office visit.  Figure 5 shows that the number of HIV tests ordered during office visits 
for each year were similar when comparing 2017 to 2018 data, 405 (2017) and 403 (2018).  The 
second most common encounter to order an HIV test was the clinical support encounter in 2018.  
This encounter is created when a clinic staff member, a nurse or CMA, actually entered the order 
in the EMR, which then needed to be co-signed by the provider.  Figure 5 also shows that when 
comparing 2017 to 2018, telephone encounters had a similar number of HIV tests ordered for 
that specific encounter.  
 
 
Figure 5. Comparison between 2017 and 2018 data for HIV tests ordered under the seven 
different patient encounters in Epic. 
 
 
The HIV Tests Ordered by Age Group  
The 2013 USPSTF recommendations for routine HIV screening include all patients ages 
15 to 65.  The clinic where this DNP project took place typically sees patients who are 18 years 
old and older, with the average age between 55 and 60 years old.  However, they do occasionally 
see patients under 18 years old.  The most common age groups for HIV tests ordered include 
those patients ages 50 to 59 years old, 60 to 65 years old and 40 to 49 years old, respectively 
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(Figure 6).  There was only one HIV test ordered for a patient in the age group 15 to 19 years 
old, which occurred in 2017.   
Several HIV tests were ordered among patients that were over the age of 66 years old in 
both 2017 and 2018.  It is recommended to screen patients over the age of 65 if they are 
considered at a high-risk of becoming infected with HIV.  In 2017, there were 34 patients over 
the age of 65 who had an HIV test; and in 2018, there were 52 patients over the age of 65 were 
tested for HIV (Figure 6). It is not known whether or not these patients were considered a high-
risk for HIV infection. 
 
 
Figure 6. Comparison of HIV tests ordered by age group in 2017 and 2018 during the months of 
September, October and November. 
 
 
The HIV Tests Ordered by Sex 
The distribution of HIV tests ordered for patients who are male or female was similar 
when comparing between 2017 and 2018 (Figure 7).  Men had a higher number of HIV tests 
ordered in both 2017 and 2018.  In 2018, women had one more HIV test ordered when compared 
to the number of tests ordered in 2017.  Females make up approximately 55% of the clinic’s 
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The HIV Tests Ordered by Race and Ethnicity 
 The human immunodeficiency virus can negatively affect certain races and ethnicities 
(CDC, 2018e).  The results somewhat mirror the population that this clinic serves.  The race of 
the patient population at this clinic is comprised of approximately 60% White or Caucasian, 30% 
Black or African American, 3.0% other or two or more races, 3.0% declined to answer, 2.0% 
Asian, and 1.0% American Indian or Alaska Native.  Patients who were White or Caucasian, or 
Black or African American had an HIV test ordered most often in 2017 and in 2018 during the 
months of September, October and November (Figure 8).  White or Caucasian patients had the 
most HIV tests ordered when compared to Black or African American patients.  Patients who 
self-identify as Latino had the least number of HIV tests ordered.  When compared to 2017, 
patients who were not Hispanic or Latino had similar number of HIV tests ordered in 2018 
(Figure 9).  Those patients who declined to denote their race or ethnicity were marked declined 
on the graph and those whose race or ethnicity were unavailable did not have a race or ethnicity 
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Figure 8. Comparison of the number of HIV tests ordered by race in 2017 and 2018 during the 




Figure 9. Comparison of the number of HIV tests ordered by ethnicity in 2017 and 2018 during 





The pre-intervention survey was distributed to nurse practitioners, physicians, and clinic 
staff on a rolling basis starting in August 2018 (Appendix 4).  Twenty-eight participants 
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Figure 10. Breakdown of the participants of the pre-intervention survey. 
 
 
 Of the varying roles in the clinic, one question of the survey asked the participants what 
their role in routine HIV screening was in the clinic (Table 8).  Common themes from this 
question showed the majority nurses, CMAs and front desk staff do not play a role in routine 
HIV screening practices at the clinic.  However, one CMA did answer that they ‘provide health 
care services for patients who have received routine HIV testing or screening’ and one nurse 
answered they are involved with order entry or education of patients and staff.  The nurse 
practitioners and physicians both answered similarly what their roles are in routine HIV 
screening; however, the physicians indicated they are also involved in management or 
administrative duties related to routine HIV testing and play a role in teaching other health care 
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Table 8. Pre-Intervention Survey Participant Responses to Role(s) in HIV Testing at the Clinic. 
 
Nurse Practitioner – Conduct HIV testing; Provide health care services for patients who have 
received routine HIV testing/screening; Teach other health care providers or students about 
routine HIV testing 
 
Physicians – Management or administrative role in routine HIV testing; Supervise staff 
conducting HIV testing; Conduct HIV testing; Provide health care services for patients who 
have received routine HIV testing/screening 
 
Manager – Supervise staff conducting HIV testing 
 
Nurses – No role; Other-order entry or education (patient and staff) 
 
Front Desk Staff – No role in routine HIV testing 
 
CMAs – No role; Provide health care services for patients who have received routine HIV 
testing/screening 
This table shows the pre-intervention survey responses of the participants who answered the 




The post-intervention survey was distributed to providers and clinic staff in January and 
February 2019 (Appendix 4 & 5).  Twenty-five participants completed the post-intervention 
survey (Figure 11).  Three providers who took the pre-intervention survey that had left the 
practice before the end of the intervention period.  One new provider that did not take the pre-
intervention survey took the post-intervention survey.  The number of participants changed in all 
roles from the pre-intervention to post-intervention period, with the exception of the manager, 
which remained the same during the intervention period (Figure 11).  This survey included the 
same questions as the pre-intervention survey with the exception of three short answer questions 
at the end of the survey (Appendix 5). 
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Figure 11. Breakdown of the participants in the post-intervention survey.  
 
 
The participants were again asked what role they play in routine HIV screening at the 
clinic (Table 9).  The front desk staff and the CMAs both responded that they play no role in 
routine HIV testing.  The nurses were more responsive and had a change in their responses to 
their role in routine HIV screening from the pre-intervention survey (Table 9).  The nurses 
answered they have a management or administrative role in routine HIV testing, they supervise 
staff conducting HIV testing, teach other health care providers or students about routine HIV 
testing, and educate patients.  One nurse did respond they did not play a role in HIV testing at the 
time the survey was distributed.  The nurse practitioners and physicians had similar answers in 
the post-intervention survey.  One provider who responded that they do not play a role in routine 
HIV testing at the time the survey was distributed.  Different providers took the pre-survey and 
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Table 9. Post-Intervention Survey Participant Responses to Role(s) in HIV Testing at the Clinic. 
 
Nurse Practitioner – Conduct HIV testing; Provide health care services for patients who have 
received routine HIV testing/screening 
 
Physicians – Management or administrative role in routine HIV testing; Supervise staff 
conducting HIV testing; Conduct HIV testing; Provide health care services for patients who 
have received routine HIV testing/screening; Teach other health care providers or students 
about routine HIV testing; No role in routine HIV testing 
 
Manager – Supervise staff conducting HIV testing 
 
Nurses – Management or administrative role in routine HIV testing; Supervise staff 
conducting HIV testing; Teach other health care providers or students about routine HIV 
testing; No role in routine HIV testing; Other-educate patients 
 
CMAs and Front Desk Staff – No role in routine HIV testing 
         
These are the responses the participants of the post-intervention survey chose when asked the 
question; “What is your role in routine HIV testing? (Check all that apply).” 
 
 
Pre- and Post-Intervention Survey Results 
The survey data from the pre- and post-intervention surveys were evaluated using seven 
topics recommended from the evaluation toolkit from the CDC (2012) (Table 10).  These seven 
topics include: the role of routine HIV testing in health care, routine HIV testing and the process 
of care, voluntary testing and consent, adequacy of patient information for testing, 
confidentiality, HIV-related stigma, and barriers/facilitators of routine HIV testing.  Each topic 
has a specific question or questions associated with that topic which is outlined in Table 10.  The 
topics with multiple questions associated with it have some positive and some negative 
questions.  These questions have been identified in Table 10.  The number of participants for 
each topic may vary depending on the number of participants who completed the survey as well 
as provided an answer to that specific question.  Twenty-eight participants completed the pre-
intervention survey and 25 participants completed the post-intervention survey.  Those that are 
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included in the pre-survey group (N=28) may or may not have completed the post-survey 
(N=25) and vice versa.   
Group Statistics of All Survey Participants 
The group statistics for the project includes all participants who completed both the pre- 
and post-intervention survey. Not all participants answered every question of the survey, which 
is one reason why the number of participants (N) varies from topic to topic.  Additionally, not all 
survey participants in section B provided a response of; strongly disagree=1, disagree=2, 
neither agree or disagree=3, agree=4, or strongly agree=5; and in section C not all participants 
provided a response of; never=1, rarely=2, about half the time=3, most of the time=4, or almost 
always or always=5.  Other possible responses include; don’t know and not applicable for both 
section B and section C.  For statistical purposes, those participants who responded to questions 
with the answer of don’t know or not applicable, were not included in the statistical analysis of 
the seven topics therefore, the number of participants (N) may be different with each topic.  Also, 
for the statistical analysis, the negative questions were reversely coded and displayed separately 
from the positive questions in each of the seven topics.  The reverse coded responses were 
recoded as follows: for section B; strongly disagree=5, disagree=4, neither agree or 
disagree=3, agree=2, or strongly agree=1 and for section C; never=5, rarely=4, about half the 
time=3, most of the time=2, or almost always or always=1.  The data were analyzed through 
SPSS software.  
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Table 10. List of Topics Used to Evaluate the Survey Data. 
Topics and Items for Survey Evaluation 
Topic Question  Survey Question 
Role of routine HIV testing in 
health care 
Section B. 1 “I think routine HIV testing is an important part of regular 
health care” (Positive) 
Routine HIV testing and the 
process of care 
Section B. 3 “I am concerned that patients will be offended by being offered 
routine HIV testing” (Negative) 
 Section B. 
13 
“We have the resources needed to implement routine HIV 
testing” (Positive) 
 Section C. 1 “Routine HIV testing interferes with providing other health care 
services” (Negative) 
 Section C. 3 “Results of routine HIV testing are documented and available to 
health care providers taking care of the patient” (Positive) 
 Section C. 4 “Patients are concerned or upset by routine HIV testing” 
(Negative) 
 Section C. 7 “Patients who test positive receive appropriate referrals for 
follow-up” (Positive) 
Voluntary testing and consent Section B. 6 “Patients often feel like they have to accept routine HIV testing” 
(Negative) 
 Section B. 
10 
“Routine HIV testing is voluntary; patients are able to decline 
screening” (Positive) 
Adequacy of patient 
information for testing 
Section B. 7 “Patients receive adequate pre-test information for routine HIV 
testing” (Positive) 
 Section B. 8 “Patients receive adequate post-test information for routine HIV 
testing” (Positive) 
 Section C. 6 “Patients understand the information they receive about routine 
HIV testing” (Positive) 
Confidentiality Section B. 9 “Patients are concerned about the confidentiality of routine HIV 
testing” (Negative) 
 Section B. 
14 
“It is difficult to provide the privacy needed for routine HIV 
testing” (Negative)  
 Section C. 2 “Patients are given HIV test results in a confidential, 
appropriate manner” (Positive) 
HIV-related stigma Section B. 3 “I am concerned that patients will be offended by being offered 
routine HIV testing” (Negative) 
 Section C. 4 “Patients are concerned or upset by routine HIV testing” 
(Negative) 
Barriers/Facilitators of 
routine HIV testing 
Section B. 2 “I am concerned about cost and reimbursement for HIV testing” 
(Negative) 
 Section B. 4 “I am comfortable discussing routine HIV testing with patients” 
(Positive) 
 Section B. 5 “Language barriers prevent some patients from receiving 
routine HIV testing” (Negative) 
 Section B. 
11 
“Patients do not expect to be offered routine HIV testing” 
(Negative) 
 Section B. 
12 
“I am concerned that routine HIV testing will have a negative 
effect on patients’ opinions about our health care 
facility/clinic/emergency department/practice” (Negative) 
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The first topic evaluated was related to the role of routine HIV testing in health care.  
This topic includes one positively worded question.  The mean response to participants 
understanding that “routine HIV testing is an important part of regular health care” increased 
slightly from 4.25 to 4.52, demonstrating a slight trend from agree to strongly agree (Table 11).   
 
Table 11. Topic: Role of Routine HIV Testing in Health Care. Group Statistic Results for Pre-
and Post-Intervention Survey. Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, 
Agree=4, Strongly Agree=5. 
Role of Routine HIV Testing in Health Care 
Question: 
Section B. 1 “I think routine HIV testing is an important part of regular health care” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 4.25 1.143 0.216 
Post-survey 25 4.52 0.586 0.117 
 
The second topic evaluated is routine HIV testing and the process of care. Table 12 
shows the three negatively worded questions relating to the topic of routine HIV testing and the 
process of care.  These questions were reverse coded for data analysis.  The mean response to 
participants being concerned “that patients will be offended by being offered routine HIV 
testing,” concerned that “routine HIV testing interferes with providing other health services,” and 
“patients concerned or upset by routine HIV testing” increased slightly from 3.49 to 3.61, 
demonstrating a slight trend from an answer of neither agree or disagree or about half the time to 
disagree or rarely (Table 12).  Table 13 shows the three positively worded questions relating to 
the topic of routine HIV testing and the process of care.  The mean response to participants 
having “the resources needed to implement routine HIV testing,” the “results of routine HIV 
testing are documented and available to health care providers taking care of the patient,” and 
knowing “patients who test positive receive appropriate referrals for follow-up” increased from 
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4.31 to 4.59, demonstrating a slight trend from agree or most of the time, to strongly agree or 
almost always or always. 
 
Table 12. Topic: Routine HIV Testing and the Process of Care. Group Statistic Results for Pre-
and Post-Intervention Survey.  Negative Questions Reverse Coded: Section B- Strongly 
disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1 and 
Section C - Never=5, Rarely=4, About Half the Time=3, Most of the Time=2, or Almost Always 
or Always=1. 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 1 “Routine HIV testing interferes with providing other health care services” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 3.49 0.667 0.126 
Post-survey 25 3.61 0.625 0.125 
 
 
Table 13. Topic: Routine HIV Testing and the Process of Care.  Group Statistic Results for Pre-
and Post-Intervention Survey. Positive Survey Questions: Section B - Strongly disagree=1, 
Disagree=2, Neither Agree or Disagree= 3, Agree=4, Strongly Agree=5 and Section C - 
Never=1, Rarely=2, About Half the Time=3, Most of the Time=4, or Almost Always or 
Always=5. 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 13 “We have the resources needed to implement routine HIV testing” 
Section C. 3 “Results of routine HIV testing are documented and available to health care 
providers taking care of the patient” 
Section C. 7 “Patients who test positive receive appropriate referrals for follow-up” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 4.31 0.669 0.129 
Post-survey 25 4.59 0.417 0.085 
 
 
 The third topic evaluated is the topic about voluntary testing and consent.  This topic has 
one negatively worded question that was reversely coded for analysis.  Table 14 shows the 
negative question related to voluntary testing and consent.  The mean response to participants 
being concerned that “patients often feel like they have to accept routine HIV testing” decreased 
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from 3.54 to 3.35 (Table 14).  This slight decrease in mean demonstrates a trend from a neutral 
answer of neither agree or disagree to answer of agree. 
 Table 15 shows the positive question that relates to the topic of voluntary testing and 
consent.  The mean response to participants feeling that “routine HIV testing is voluntary; 
patients are able to decline screening” increased from 4.35 to 4.5, demonstrating a slight trend 
from agree toward strongly agree (Table 15). 
 
Table 14. Topic: Voluntary Testing and Consent.  Group Statistic Results for Pre-and Post-
Intervention Survey. Negative Questions Reverse Coded: Section B- Strongly disagree=5, 
Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1. 
Voluntary Testing and Consent 
Question: 
Section B. 6 “Patients often feel like they have to accept routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 24 3.54 0.833 0.170 
Post-survey 23 3.35 0.885 0.184 
 
 
Table 15. Topic: Voluntary Testing and Consent.  Group Statistic Results for Pre-and Post-
Intervention Survey. Positive Survey Questions: Section B - Strongly disagree=1, Disagree=2, 
Neither Agree or Disagree= 3, Agree=4, Strongly Agree=5. 
Voluntary Testing and Consent 
Question: 
Section B. 10 “Routine HIV testing is voluntary; patients are able to decline screening” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 4.35 0.621 0.117 
Post-survey 22 4.5 0.676 0.143 
 
 
 The next topic evaluated is the adequacy of patient information for testing.  Table 16 
shows the three questions associated with this topic that are all positively worded.  The mean 
response to participants understanding the “patients received adequate pre-and post-test 
information for routine HIV testing” and the “patients understand the information they receive 
about routine HIV testing” increased from 3.14 to 3.53, demonstrating a trend from a neutral 
response to a response of agree or most of the time (Table 16). 
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Table 16. Topic: Adequacy of Patient Information for Testing. Group Statistic Results for the 
Pre-and Post-Intervention Survey.  Positive Questions: Section B - Strongly disagree=1, 
Disagree=2, Neither Agree or Disagree= 3, Agree=4, Strongly Agree=5 and Section C - 
Never=1, Rarely=2, About Half the Time=3, Most of the Time=4, or Almost Always or 
Always=5. 
Adequacy of Patient Information for Testing 
Questions: 
Section B. 7 “Patients receive adequate pre-test information for routine HIV testing” 
Section B. 8 “Patients receive adequate post-test information for routine HIV testing” 
Section C. 6 “Patients understand the information they receive about routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 26 3.14 0.688 0.135 
Post-survey 24 3.53 0.611 0.125 
 
 
 The next topic evaluated is confidentiality.  Table 17 shows the two negatively worded 
questions relating to confidentiality and routine HIV testing.  The mean response to participants’ 
perspectives that the “patients are concerned about the confidentiality of routine HIV testing” 
and the difficulty “to provide the privacy needed for routine HIV testing” increased from 3.30 to 
3.58, demonstrating a slight trend from a neutral response toward a response of disagree (Table 
17).  Table 18 shows the positive question related to the topic of confidentiality and routine HIV 
testing.  The mean response to participants’ perspective that “patients are given HIV test results 
in a confidential, appropriate manner” increased slightly from 4.47 to 4.85, demonstrating a 
slight trend from a response of agree to a response of strongly agree (Table 18). 
  
   
56 
Table 17. Topic: Confidentiality. Group Statistic Results for Pre-and Post-Intervention Survey. 
Negative Questions Reverse Coded: Section B- Strongly disagree=5, Disagree=4, Neither Agree 
or Disagree= 3, Agree=2, Strongly Agree=1. 
Confidentiality 
Questions: 
Section B. 9 “Patients are concerned about the confidentiality of routine HIV testing” 
Section B. 14 “It is difficult to provide the privacy needed for routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 3.30 1.003 0.190 
Post-survey 24 3.58 0.702 0.143 
 
 
Table 18. Topic: Confidentiality. Group Statistic Results for the Pre-and Post-Intervention 
Survey.  Positive Question: Section C - Never=1, Rarely=2, About Half the Time=3, Most of the 
Time=4, or Almost Always or Always=5. 
Confidentiality 
Question: 
Section C. 2 “Patients are given HIV test results in a confidential, appropriate manner” 
Group N Mean SD Standard Error Mean 
Pre-survey 23 4.74 0.449 0.094 
Post-survey 20 4.85 0.366 0.082 
 
 
 The sixth topic evaluated is HIV-related stigma. Table 19  shows the two negatively 
worded questions relating to the stigma associated with routine HIV screening.  The mean 
response to participants being concerned “that patients will be offended by being offered routine 
HIV testing” and “are concerned or upset by routine HIV testing” increased slightly from 3.14 to 
3.38, demonstrating a slight trend from a neutral response of neither agree or disagree or about 
half the time, to a response of disagree or rarely (Table 19). 
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Table 19. Topic: HIV-Related Stigma.  Group Statistic Results for the Pre-and Post-Intervention 
Survey.  Negative Questions Reverse Coded: Section B- Strongly disagree=5, Disagree=4, 
Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1 and Section C - Never=5, Rarely=4, 
About Half the Time=3, Most of the Time=2, or Almost Always or Always=1. 
HIV-Related Stigma 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 3.14 0.744 0.140 
Post-survey 25 3.38 0.666 0.133 
 
 
 The last topic evaluated discusses the barriers and facilitators of routine HIV testing.  
This topic contains four negatively worded questions and one positively worded question.  Table 
20 shows the group statistics for all survey participants for the negatively worded questions.  The 
mean response to participants being “concerned about cost and reimbursement for HIV testing,” 
the perspective of “language barriers prevent some patients from receiving routine HIV testing,” 
and being “concerned that routine HIV testing will have a negative effect on patients’ opinions 
about our health care facility” increased slightly from 3.01 to 3.12, demonstrating a slight trend 
from a neutral response of neither agree or disagree towards a response of disagree (Table 20).  
Table 21 shows the group statistics of all survey participants for the positively worded question 
for the topic of barriers and facilitators of routine HIV testing.  The mean response to 
participants being “comfortable discussing routine HIV testing with patients” increased slightly 
from 3.80 to 3.96, demonstrating a trend from a response of neither agree or disagree to a 
response of agree (Table 21). 
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Table 20. Topic: Barriers/Facilitators of Routine HIV Testing.  Group Statistic Results for the 
Pre-and Post-Intervention Survey. Negative Questions Reverse Coded: Section B- Strongly 
disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1. 
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 2 “I am concerned about cost and reimbursement for HIV testing” 
Section B. 5 “Language barriers prevent some patients from receiving routine HIV testing” 
Section B. 11 “Patients do not expect to be offered routine HIV testing” 
Section B. 12 “I am concerned that routine HIV testing will have a negative effect on 
patients’ opinions about our health care facility/clinic/emergency 
department/practice” 
Group N Mean SD Standard Error Mean 
Pre-survey 28 3.01 0.731 0.138 
Post-survey 25 3.12 0.559 0.112 
 
 
Table 21. Topic: Barriers/Facilitators of Routine HIV Testing.  Group Statistic Results for the 
Pre-and Post-Intervention Survey. Positive Question: Section B - Strongly disagree=1, 
Disagree=2, Neither Agree or Disagree= 3, Agree=4, Strongly Agree=5.  
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 4 “I am comfortable discussing routine HIV testing with patients” 
Group N Mean SD Standard Error Mean 
Pre-survey 25 3.80 0.866 0.173 
Post-survey 24 3.96 0.859 0.175 
 
 Pre-and post-intervention survey participant analysis.   The participants who 
completed both the pre-and the post-intervention survey were evaluated using paired sample 
statistics and two-tailed t-tests in SPSS software.  The participants included in this analysis are 
the physicians, nurse practitioners, nurses, CMAs, manager, and front desk staff.  The surveys 
were paired utilizing the confidential dummy identifier, a unique number that was assigned to the 
participants when they took the pre-intervention survey.  The number was used to match their 
pre-intervention survey with the post-intervention survey.  The sample size (N) is the number of 
participants who completed both the pre-and post-intervention survey (N=22).  The seven topics 
from Table 10 were used and broken down individually by topic and separated by negatively and 
positively worded questions.  If a participant did not answer the question with a response of 
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strongly disagree, disagree, neither agree or disagree, agree, strongly agree, in section B; or 
never, rarely, about half the time, most of the time, almost always or always in section C; then 
their answer was not included in the analysis of that question, therefore, the number of 
participants (N) may vary with each topic.  The positively worded questions were scored as 
strongly disagree=1, disagree=2, neither agree or disagree= 3, agree=4, strongly agree=5 for 
section B and never=1, rarely=2, about half the time=3, most of the time=4, almost always or 
always=5 for section C.  The negatively worded questions were reversely coded as follows; 
strongly disagree=5, disagree=4, neither agree or disagree= 3, agree=2, strongly agree=1 for 
section B and never=5, rarely=4, about half the time=3, most of the time=2, almost always or 
always=1. 
 The first topic on the role of routine HIV testing in health care evaluates the participants’ 
perspective on the importance of HIV screening in regular health care.  Table 22 shows the one 
question associated with the topic of routine HIV testing in health care and it is positively 
worded.  The mean response to participants thinking that “routine HIV testing is an important 
part of regular health care” increased slightly from 4.41 to 4.55 (p=0.544), demonstrating a slight 
trend from agree to strongly agree.  Table 23 shows the paired differences in the pre- and post-
intervention surveys on the topic related to routine HIV testing in health care.  The surveys were 
paired with confidential identifier assigned to the participant at the start of the intervention.  The 
mean difference from the pre-survey to the post-survey was -0.136 (Table 23).  There was a 
slight improvement in the mean Likert scores from the pre-survey to the post-survey that were 
trending towards a response of strongly agree.  
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Table 22. Topic: Role of Routine HIV Testing in Health Care.  Paired Sample Statistics for 
Participants Who Completed Both the Pre-and Post-Intervention Survey.  Positive Question: 
Section B - Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, Agree=4, Strongly 
Agree=5. 
Role of Routine HIV Testing in Health Care 
Question: 
Section B. 1 “I think routine HIV testing is an important part of regular health care” 














Table 23. Topic: Role of Routine HIV Testing in Health Care.  Paired Differences in Pre- and 
Post-Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and Post-
Intervention Survey, Using a Two-Tailed t-Test. 
Role of Routine HIV Testing in Health Care 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.136 1.037 0.221 -0.596-0.323 -0.617 21 0.544 
Note.  CI = Confidence Interval 
 
 
The next topic evaluated is routine HIV testing and the process of care.  Table 24 shows 
the three negatively worded questions relating to routine HIV testing and the process of care.  
The mean response to participants being “concerned that patients will be offended by being 
offered routine HIV testing,” or “ patients are concerned or upset by routine HIV testing,” and 
that “routine HIV testing interferes with providing other health care services” increased slightly 
from 3.41 to 3.51 (p=0.120), demonstrating a slight trend from a response of neither agree or 
disagree or about half the time, towards a response of disagree (Table 24).  Table 25 shows the 
paired differences in the pre- and post-intervention surveys on the topic of routine HIV testing 
and the process of care.  The mean difference from the pre-to post- survey was   
-0.197, which demonstrates a slight improvement in mean Likert scores from the pre-to the post-
survey. 
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 Table 26 shows the three positively worded questions for the topic of routine HIV testing 
and the process of care.  The mean response to participants’ perspectives of having “the 
resources needed to implement routine HIV testing,” that the “results of routine HIV testing are 
documented and available to health care providers taking care of the patient,” and “patients who 
test positive receive appropriate referrals for follow up” increased from 4.34 to 4.58 (p=0.074), 
demonstrating a slight trend from agree or most of the time towards a response of strongly agree, 
or almost always or always.  Table 27 shows the paired differences from the pre- and post-
intervention surveys for the topic of routine HIV testing and the process of care.   The mean 
difference from the pre- to the post-survey was -0.238 (Table 27).  This shows there was a slight 
difference in mean Likert score from the pre-survey to the post-survey trending towards the 
response of strongly agree, or almost always or always. 
 
Table 24. Topic: Routine HIV Testing and the Process of Care.  Paired Sample Statistics for 
Participants Who Completed Both the Pre-and Post-Intervention Survey. Negative Questions 
Reverse Coded: Section B- Strongly disagree=5, Disagree=4, Neither Agree or Disagree= 3, 
Agree=2, Strongly Agree=1 and Section C - Never=5, Rarely=4, About Half the Time=3, Most 
of the Time=2, or Almost Always or Always=1. 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 1 “Routine HIV testing interferes with providing other health care services” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 22 3.41 0.656 0.140 
Post-survey 22 3.61 0.610 0.130 
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Table 25. Topic: Routine HIV Testing and the Process of Care.  Paired Differences in the Pre- 
and Post-Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and 
Post-Intervention Survey, Using a Two-Tailed t-Test. (Negative Questions). 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 1 “Routine HIV testing interferes with providing other health care services” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.197 0.570 0.121 -0.450-0.556 -1.622 21 0.120 
Note.  CI = Confidence Interval 
 
 
Table 26. Topic: Routine HIV Testing and the Process of Care.  Paired Sample Statistics for 
Participants Who Completed Both the Pre-and Post-Intervention Survey. Positive Survey 
Questions: Section B - Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, 
Agree=4, Strongly Agree=5 and Section C - Never=1, Rarely=2, About Half the Time=3, Most 
of the Time=4, or Almost Always or Always=5. 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 13 “We have the resources needed to implement routine HIV testing” 
Section C. 3 “Results of routine HIV testing are documented and available to health care 
providers taking care of the patient” 
Section C. 7 “Patients who test positive receive appropriate referrals for follow-up” 
Group N Mean SD Standard Error Mean 
Pre-survey 21 4.34 0.678 0.148 
Post-survey 21 4.58 0.433 0.095 
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Table 27. Topic: Routine HIV Testing and the Process of Care.  Paired Differences in Pre- and 
Post-Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and Post-
Intervention Survey, Using a Two-Tailed t-Test. (Positive Questions). 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 13 “We have the resources needed to implement routine HIV testing” 
Section C. 3 “Results of routine HIV testing are documented and available to health care 
providers taking care of the patient” 
Section C. 7 “Patients who test positive receive appropriate referrals for follow-up” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.238 0.579 0.126 -0.501-0.253 -1.885 20 0.074 
Note.  CI = Confidence Interval 
 
The third topic evaluated is voluntary testing and consent.  This topic has one negatively 
worded question and one positively worded question.  Table 28 shows the negatively worded 
question.  The mean response to participants’ perspective about “patients often feel like they 
have to accept routine HIV testing” decreased from 3.50 to 3.35 (p=0.592), demonstrating a 
trend downwards from a neutral answer of neither agree or disagree to a response of agree (Table 
28).  Table 29 shows the paired differences from the pre-and post-intervention surveys that have 
a mean difference of 0.167.  There mean Likert scores did not improve for this question in the 
post-survey as the responses were trending towards the response of agree. 
 Table 30 shows the one positively worded question related to the topic of voluntary 
testing and consent.  The mean response to participants’ perspectives that “routine HIV testing is 
voluntary; patients are able to decline screening” increased from 4.45 to 4.60 (p=0.419), 
demonstrating a slight trend from a response of agree to a response of strongly agree.  The mean 
difference from the pre-survey to post-survey was -0.150 (Table 31).  The mean Likert scores 
slightly improved towards a response of strongly agree from agree.  
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Table 28. Topic: Voluntary Testing and Consent.  Paired Sample Statistics for Participants Who 
Completed Both the Pre-and Post-Intervention Survey. Negative Question Reverse Coded: 
Section B- Strongly disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly 
Agree=1. 
Voluntary Testing and Consent 
Question: 
Section B. 6 “Patients often feel like they have to accept routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 18 3.50 0.786 0.185 
Post-survey 18 3.35 0.907 0.214 
 
 
Table 29. Topic: Voluntary Testing and Consent.  Paired Differences in Pre- and Post-
Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and Post-
Intervention Survey, Using a Two-Tailed t-Test. (Negative Question). 
Voluntary Testing and Consent 
Question: 
Section B. 6 “Patients often feel like they have to accept routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
0.167 1.29 0.305 -0.477-0.811 0.546 17 0.592 
Note.  CI = Confidence Interval 
 
 
Table 30. Topic: Voluntary Testing and Consent.  Paired Sample Statistics for Participants Who 
Completed Both the Pre-and Post-Intervention Survey.  Positive Survey Question: Section B - 
Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, Agree=4, Strongly Agree=5. 
Voluntary Testing and Consent 
Question: 
Section B. 10 “Routine HIV testing is voluntary; patients are able to decline screening” 
Group N Mean SD Standard Error Mean 
Pre-survey 20 4.45 0.605 0.135 
Post-survey 20 4.60 0.598 0.134 
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Table 31. Topic: Voluntary Testing and Consent.  Paired Differences in Pre- and Post-
Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and Post-
Intervention Survey, Using a Two-Tailed t-Test. (Positive Question). 




“Routine HIV testing is voluntary; patients are able to decline screening” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.150 0.813 0.182 -0.530-0.230 -0.825 19 0.419 
Note.  CI = Confidence Interval 
 
 The next topic evaluated is the adequacy of patient information for testing.  This topic 
consists of three questions that are all positively worded (Table 32).  The mean response to 
participants’ perspective that “patients receive adequate pre- and post-test information for routine 
HIV testing” and “patients understand the information they receive about routine HIV testing” 
increased from 3.17 to 3.55 (p=0.015), demonstrating a trend from a neutral response to a 
response of agree or most of the time (Table 32).   Table 33 shows the paired differences in the 
pre- and post-survey responses, which had a mean difference of -0.383.  The p value of 0.015 is 
less than the cut-off of the alpha score of 0.05; however, because of the small sample size, this 
cannot be considered statistically significant. 
 
Table 32. Topic: Adequacy of Patient Information for Testing. Paired Sample Statistics for 
Participants Who Completed Both the Pre-and Post-Intervention Survey.  Positive Survey 
Questions: Section B - Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, 
Agree=4, Strongly Agree=5 and Section C - Never=1, Rarely=2, About Half the Time=3, Most 
of the Time=4, or Almost Always or Always=5. 
Adequacy of Patient Information for Testing 
Questions: 
Section B. 7 “Patients receive adequate pre-test information for routine HIV testing” 
Section B. 8 “Patients receive adequate post-test information for routine HIV testing” 
Section C. 6 “Patients understand the information they receive about routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre- 20 3.17 0.626 0.140 
Post- 20 3.55 0.633 0.142 
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Table 33. Topic: Adequacy of Patient Information for Testing.  Paired Differences in Pre- and 
Post-Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and Post-
Intervention Survey, Using a Two-Tailed t-Test. 
Adequacy of Patient Information for Testing 
Questions: 
Section B. 7 “Patients receive adequate pre-test information for routine HIV testing” 
Section C. 8 “Patients receive adequate post-test information for routine HIV testing” 
Section C. 6 “Patients understand the information they receive about routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.383 0.642 0.144 -0.684- -0.083 -2.669 19 0.015 
Note.  CI = Confidence Interval 
 
 The fifth topic evaluated is confidentiality.  This topic consists of two negatively worded 
questions and on positively worded question.  Table 34 shows the two negatively worded 
questions associated with the topic of confidentiality.  The mean response to participants’ 
perspectives that “patients are concerned about the confidentiality of routine HIV testing” and 
that “it is difficult to provide the privacy needed for routine HIV testing” increased from 3.40 to 
3.64 (p=0.219), demonstrating a slight trend from neither agree or disagree towards a response of 
disagree Table 34).  Table 35 shows the paired differences from the pre- and post-intervention 
survey.  The mean difference between the pre- and post-intervention survey was -0.238 (Table 
35).  There was a slight improvement in the mean Likert scores from the pre-survey to the post-
survey towards a response of disagree. 
 Table 36 shows the positively worded question related to the topic of confidentiality.  
The mean response to participants’ perspectives that “patients are given HIV test results in a 
confidential, appropriate manner” increased from 4.77 to 4.83 (p=0.668), demonstrating a slight 
trend from agree to strongly agree (Table 36).  Table 37 shows the paired differences in the pre- 
and post-intervention surveys.  The mean difference from the pre-survey to the post-survey was  
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-0.056 (Table 37).  There was a slight improvement in the mean Likert scores trending towards a 
response of strongly agree. 
 
Table 34. Topic: Confidentiality.  Paired Sample Statistics for Participants Who Completed Both 
the Pre-and Post-Intervention Survey. Negative Questions Reverse Coded: Section B- Strongly 
disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1. 
Confidentiality 
Questions: 
Section B. 9 “Patients are concerned about the confidentiality of routine HIV testing” 
Section B. 14 “It is difficult to provide the privacy needed for routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 21 3.40 0.831 0.181 
Post-survey 21 3.64 0.727 0.159 
 
 
Table 35. Topic: Confidentiality.  Paired Differences in Pre- and Post-Intervention Survey Data 
in All Survey Participants Who Completed Both a Pre- and Post-Intervention Survey, Using a 
Two-Tailed t-Test. (Negative Questions). 
Confidentiality 
Questions: 
Section B. 9 “Patients are concerned about the confidentiality of routine HIV testing” 
Section B. 14 “It is difficult to provide the privacy needed for routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.238 0.860 0.188 -0.630-0.154 -1.268 20 0.219 
Note.  CI = Confidence Interval 
 
 
Table 36. Topic: Confidentiality.  Paired Sample Statistics for Participants Who Completed Both 
the Pre-and Post-Intervention Survey. Positive Survey Question: Section C - Never=1, Rarely=2, 
About Half the Time=3, Most of the Time=4, or Almost Always or Always=5. 
Confidentiality 
Question: 
Section C. 2 “Patients are given HIV test results in a confidential, appropriate manner” 
Group N Mean SD Standard Error Mean 
Pre-survey 18 4.77 0.428 0.101 
Post-survey 18 4.83 0.383 0.090 
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Table 37. Topic: Confidentiality.  Paired Differences in Pre- and Post-Intervention Survey Data 
in All Survey Participants Who Completed Both a Pre- and Post-Intervention Survey, Using a 
Two-Tailed t-Test. (Positive Questions). 
Confidentiality 
Questions: 
Section C. 2 “Patients are given HIV test results in a confidential, appropriate manner” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.056 0.539 0.127 -0.324-0.213 -0.437 17 0.668 
Note.  CI = Confidence Interval 
 
 
 The sixth topic evaluated is HIV-related stigma.  Table 38 shows the two negatively 
worded questions relating to the stigma associated with routine HIV screening.  The mean 
response to participants being “concerned that patients will be offended by being offered routine 
HIV testing and “patients being concerned or upset by routine HIV testing” increased from 3.07 
to 3.27 (p=0.186), demonstrating a slight trend from a response close to agree to a more neutral 
response (Table 38).  The mean difference of the pre- and post-survey responses was -0.205 
(Table 39).  There was a slight improvement in the mean Likert scores from a response close to 
agree to a more neutral response. 
 
Table 38. Topic: HIV-related Stigma.  Paired Sample Statistics for Participants Who Completed 
Both the Pre- and Post-Intervention Survey. Negative Survey Questions: Section B - Strongly 
disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1 and 




Section B. 3 “I am concerned that patients will be offended by being offered routine HIV testing” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Group N Mean SD Std. Error Mean 
Pre-survey 22 3.07 0.660 0.141 
Post-survey 22 3.27 0.631 0.135 
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Table 39. Topic: HIV-Related Stigma.  Paired Differences in Pre- and Post-Intervention Survey 
Data in All Survey Participants Who Completed Both a Pre- and Post-Intervention Survey, 
Using a Two-Tailed t-Test. 
HIV-Related Stigma 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.205 0.701 0.149 -0.515-0.106 -1.368 21 0.186 
Note.  CI = Confidence Interval 
 
 The seventh topic evaluated in the pre-and post-survey is barriers and facilitators of 
routine HIV testing.  Table 40 shows the three negatively worded questions related to the topic 
of barriers and facilitators of routine HIV testing.  The mean response to participants being 
“concerned about cost and reimbursement for HIV testing,” concerned that “language barriers 
prevent some patients from receiving routine HIV testing,” and being concerned “that routine 
HIV testing will have a negative effect on patients’ opinions about our health care facility” 
increased from 2.96 to 3.12 (p=0.237), demonstrating a slight trend from a response of agree to a 
neutral response of neither agree or disagree (Table 40).  Table 41 shows the paired differences 
in the pre- and post-survey responses for the topic on the barriers and facilitators of routine HIV 
testing.  The mean difference of the pre- and post-survey was -0.167 (Table 41).  There was a 
slight improvement in the mean Likert scores, from an answer of agree rending towards an 
answer of neither agree or disagree. 
 Table 42 shows one positively worded question related to the topic of barriers and 
facilitators of routine HIV testing.  The mean response to participants’ perspective that they are 
“comfortable discussing routine HIV testing with patients” increased from 3.85 to 4.0 (p=0.267), 
demonstrating a trend from a neutral response of neither agree or disagree to a response of agree.  
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Table 43 shows the paired differences in the pre- and post-intervention surveys for the topic on 
the barriers and facilitators of routine HIV testing.  The mean difference from the pre-survey to 
the post-survey was -0.150 (Table 43).  There was an improvement in the mean Likert scores 
from a neutral response to a response of agree. 
 
Table 40. Topic: Barriers/Facilitators of Routine HIV Testing.  Paired Sample Statistics for 
Participants Who Completed Both the Pre-and Post-Intervention Survey. Negative Questions 
Reverse Coded: Section B- Strongly disagree=5, Disagree=4, Neither Agree or Disagree= 3, 
Agree=2, Strongly Agree=1. 
Barriers/Facilitators of routine HIV testing 
Questions: 
Section B. 2 “I am concerned about cost and reimbursement for HIV testing” 
Section B. 5 “Language barriers prevent some patients from receiving routine HIV testing” 
Section B. 11 “Patients do not expect to be offered routine HIV testing” 
Section B. 12 “I am concerned that routine HIV testing will have a negative effect on 
patients’ opinions about our health care facility/clinic/emergency 
department/practice” 
Group N Mean SD Standard Error Mean 
Pre-survey 22 2.96 0.730 0.156 
Post-survey 22 3.12 0.591 0.126 
 
 
Table 41. Topic: Barriers/Facilitators of Routine HIV Testing.  Paired Differences in the Pre- 
and Post-Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and 
Post-Intervention Survey, Using a Two-Tailed t-Test. (Negative Questions). 
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 2 “I am concerned about cost and reimbursement for HIV testing” 
Section B. 5 “Language barriers prevent some patients from receiving routine HIV testing” 
Section B. 11 “Patients do not expect to be offered routine HIV testing” 
Section B. 12 “I am concerned that routine HIV testing will have a negative effect on 
patients’ opinions about our health care facility/clinic/emergency 
department/practice” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.167 0.642 0.137 -0.451-0.118 -1.218 21 0.237 
Note.  CI = Confidence Interval 
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Table 42. Topic: Barriers/Facilitators of Routine HIV Testing.  Paired Sample Statistics for 
Participants Who Completed Both the Pre-and Post-Intervention Survey. Positive Survey 
Questions: Section B - Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, 
Agree=4, Strongly Agree=5. 
Barriers/Facilitators of routine HIV testing 
Questions: 
Section B. 4 “I am comfortable discussing routine HIV testing with patients” 
Group N Mean SD Standard Error Mean 
Pre-survey 20 3.85 0.813 0.182 
Post-survey 20 4.00 0.918 0.205 
 
 
Table 43. Topic: Barriers/Facilitators of Routine HIV Testing.  Paired Differences in Pre- and 
Post-Intervention Survey Data in All Survey Participants Who Completed Both a Pre- and Post-
Intervention Survey, Using a Two-Tailed t-Test. (Positive Questions). 
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 4 “I am comfortable discussing routine HIV testing with patients” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.150 0.587 0.131 -0.425-0.125 -1.143 19 0.267 
Note.  CI = Confidence Interval 
 
 
The Provider Survey Results 
The providers of the clinic were the main focus of this project as they currently play the 
biggest role in routine HIV screening.  The providers who completed both a pre- and post-
intervention survey were analyzed using paired general statistics and paired t-tests using SPSS 
software.  The participants’ surveys were paired using the confidential identifier assigned to 
them when they completed the pre-intervention survey.  The provider group includes both 
physicians and nurse practitioners.  The sample size (N) was six for the number of providers who 
completed both surveys.  The results were separated into the seven topics in Table 10.  The 
negatively and positively worded questions were separated by topic and analyzed independently.  
The negatively worded questions were reversely scored as follows; section B: strongly 
disagree=5, disagree=4, neither agree or disagree=3, agree=2, strongly agree =1 and section 
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C: never=5, rarely=4, about half the time=3, most of the time=2, almost always or always=1.  
The positively worded questions were scored as follows; section B: strongly disagree=1, 
disagree=2, neither agree or disagree=3, agree=4, strongly agree =5 and section C: never=1, 
rarely=2, about half the time=3, most of the time=4, almost always or always=5.  The results of 
the paired t-test for the seven topics are shown in tables 44 – 64. 
 The first topic on the role of routine HIV testing in health care evaluates the providers’ 
perspective on the importance of HIV screening in regular health care.  Table 44 shows the one 
question associated with the topic of routine HIV testing in health care and it is positively 
worded.   The mean response to participants thinking that “routine HIV testing is an important 
part of regular health care” increased slightly from 4.33 to 4.55, demonstrating a slight trend 
from agree toward strongly agree.  A t-test could not be performed for this topic because there 
was not enough variation in responses, therefore, the measure was not sensitive enough for either 
the low number of participants or because of the extremely low variance. 
 
Table 44. Topic: Role of Routine HIV Testing in Health Care.  Paired Sample General Statistics 
of Providers (Nurse Practitioners and Physicians) Who Completed the Pre- and Post-
Intervention Survey (N=6).  Positive Question: Section B - Strongly disagree=1, Disagree=2, 
Neither Agree or Disagree= 3, Agree=4, Strongly Agree=5. 
Role of Routine HIV Testing in Health Care 
Question: 
Section B. 1 “I think routine HIV testing is an important part of regular health care” 
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The next topic evaluated is routine HIV testing and the process of care.  Table 45 shows 
the three negatively worded questions relating to routine HIV testing and the process of care.  
The mean response to participants being “concerned that patients will be offended by being 
offered routine HIV testing,” or “ patients are concerned or upset by routine HIV testing,” and 
that “routine HIV testing interferes with providing other health care services” increased slightly 
from 3.50 to 3.67 (p=0.203), demonstrating a slight trend from a response of neither agree or 
disagree or about half the time, towards a response of disagree (Table 45).  Table 46 shows the 
paired differences in the pre- and post-intervention surveys on the topic of routine HIV testing 
and the process of care for the negatively worded questions.  The mean difference from the pre-
to post- survey was -0.167, which demonstrates a slight improvement in mean Likert scores from 
the pre-to the post-survey. 
 Table 47 shows the three positively worded questions for the topic of routine HIV testing 
and the process of care.  The mean response to participants’ perspectives of having “the 
resources needed to implement routine HIV testing,” that the “results of routine HIV testing are 
documented and available to health care providers taking care of the patient,” and “patients who 
test positive receive appropriate referrals for follow up” increased from 4.47 to 4.83 (p=0.234), 
demonstrating a slight trend from agree or most of the time towards a response of strongly agree, 
or almost always or always.  Table 48 shows the paired differences from the pre- and post-
intervention surveys for the topic of routine HIV testing and the process of care.  The mean 
difference from the pre- to the post-survey was -0.361 (Table 48).  This shows there was a slight 
difference in mean Likert score from the pre-survey to the post-survey trending towards the 
response of strongly agree, or almost always or always. 
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Table 45. Topic: Routine HIV Testing and the Process of Care Paired Sample General Statistics 
of Providers Who Completed the Pre- and Post-Intervention Survey (N=6). Negative Questions 
Reverse Coded: Section B- Strongly disagree=5, Disagree=4, Neither Agree or Disagree= 3, 
Agree=2, Strongly Agree=1. 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 1 “Routine HIV testing interferes with providing other health care services” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 3.50 0.691 0.282 
Post-survey 6 3.67 0.869 0.355 
 
 
Table 46. Topic: Routine HIV Testing and the Process of Care (Negative Questions).  Pre-and 
Post-Intervention Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 1 “Routine HIV testing interferes with providing other health care services” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.167 0.279 0.114 -0.459-0.126 -1.464 5 0.203 
 
 
Table 47. Topic: Routine HIV Testing and the Process of Care.  Paired Sample General 
Statistics of Providers Who Completed the Pre- and Post-Intervention Survey (N=6). Strongly 
Disagree=1, Disagree=2, Neither Agree or Disagree=3, Agree=4, Strongly Agree =5 (Positive 
Question). 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 13 “We have the resources needed to implement routine HIV testing” 
Section C. 3 “Results of routine HIV testing are documented and available to health care 
providers taking care of the patient” 
Section C. 7 “Patients who test positive receive appropriate referrals for follow-up” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 4.47 0.702 0.287 
Post-survey 6 4.83 0.279 0.114 
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Table 48. Topic: Routine HIV Testing and the Process of Care (Positive Questions).  Pre-and 
Post-Intervention Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Routine HIV Testing and the Process of Care 
Questions: 
Section B. 13 “We have the resources needed to implement routine HIV testing” 
Section C. 3 “Results of routine HIV testing are documented and available to health care 
providers taking care of the patient” 
Section C. 7 “Patients who test positive receive appropriate referrals for follow-up” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.361 0.653 0.267 -1.047-0.324 -1.354 5 0.234 
 
 The third topic evaluated is voluntary testing and consent.  This topic has one negatively 
worded question and one positively worded question.  Table 49 shows the negatively worded 
question.  The mean response to providers’ perspective about “patients often feel like they have 
to accept routine HIV testing” decreased from 3.67 to 3.5 (p=0.793), demonstrating a trend 
downwards from a neutral answer of neither agree or disagree to a response of agree (Table 49).  
Table 50 shows the paired differences from the pre-and post-intervention surveys that have a 
mean difference of 0.167.  The mean Likert scores did not improve for this question in the post-
survey as the responses were trending towards the response of agree. 
 Table 51 shows the one positively worded question related to the topic of voluntary 
testing and consent.  The mean response to participants’ perspectives that “routine HIV testing is 
voluntary; patients are able to decline screening” increased from 4.67 to 5.0 (p=0.363), 
demonstrating a trend from a response of agree to a response of strongly agree.  The mean 
difference from the pre-survey to post-survey was -0.333 (Table 52).  The mean Likert scores 
improved to a response of strongly agree from agree.  
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Table 49. Topic: Voluntary Testing and Consent Paired Sample General Statistics of Providers 
Who Completed the Pre- and Post-Intervention Survey (N=6). Strongly Disagree=5, 
Disagree=4, Neither Agree or Disagree=3, Agree=2, Strongly agree =1 (Negative Question).   
Voluntary Testing and Consent 
Question: 
Section B. 6 “Patients often feel like they have to accept routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 3.67 1.032 0.422 
Post-survey 6 3.5 0.837 0.342 
 
 
Table 50. Topic: Voluntary Testing and Consent (Negative Questions).  Pre-and Post-
Intervention Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Voluntary Testing and Consent 
Question: 
Section B. 6 “Patients often feel like they have to accept routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
0.167 1.472 0.601 -1.378-1.711 0.277 5 0.793 
 
 
Table 51. Topic: Voluntary Testing and Consent Paired Sample General Statistics of Providers 
Who Completed the Pre- and Post-Intervention Survey (N=6). Strongly Disagree=1, 
Disagree=2, Neither Agree or Disagree=3, Agree=4, Strongly Agree =5 (Positive Question).   
Voluntary Testing and Consent 
Question: 
Section B. 10 “Routine HIV testing is voluntary; patients are able to decline screening” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 4.67 0.816 0.333 
Post-survey 6 5.0 0.000 0.000 
 
 
Table 52. Topic: Voluntary Testing and Consent (Positive Questions).  Pre-and Post-
Intervention Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Voluntary Testing and Consent 
Question: 
Section B. 10 “Routine HIV testing is voluntary; patients are able to decline screening” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.333 0.816 0.333 -1.190-0.523 -1.00 5 0.363 
 
The next topic evaluated is the adequacy of patient information for testing.  This topic 
consists of three questions that are all positively worded (Table 53).  The mean response to 
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providers’ perspectives that “patients receive adequate pre- and post-test information for routine 
HIV testing” and “patients understand the information they receive about routine HIV testing” 
increased from 3.06 to 3.5 (p=0.221, demonstrating a trend from a neutral response towards a 
response of agree or most of the time (Table 53).   Table 54 shows the paired differences in the 
pre- and post-survey responses, which had a mean difference of -0.444.  The mean Likert score 
did show a slight improvement from a neutral response towards a response of agree. 
 
Table 53. Topic: Adequacy of Patient Information for Testing.  Paired Sample General Statistics 
of Providers Who Completed the Pre- and Post-Intervention Survey (N=6). Positive Survey 
Questions: Section B - Strongly disagree=1, Disagree=2, Neither Agree or Disagree= 3, 
Agree=4, Strongly Agree=5 and Section C - Never=1, Rarely=2, About Half the Time=3, Most 
of the Time=4, or Almost Always or Always=5. 
Adequacy of Patient Information for Testing 
Questions: 
Section B. 7 “Patients receive adequate pre-test information for routine HIV testing” 
Section B. 8 “Patients receive adequate post-test information for routine HIV testing” 
Section C. 6 “Patients understand the information they receive about routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 3.06 0.534 0.218 
Post-survey 6 3.5 0.548 0.224 
 
 
Table 54. Topic: Adequacy of Patient Information for Testing.  Pre- and Post-Intervention 
Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Adequacy of Patient Information for Testing 
Questions: 
Section B. 7 “Patients receive adequate pre-test information for routine HIV testing” 
Section C. 8 “Patients receive adequate post-test information for routine HIV testing” 
Section C. 6 “Patients understand the information they receive about routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.444 0.779 0.318 -1.262-0.373 -1.397 5 0.221 
 
The fifth topic evaluated is confidentiality.  This topic consists of two negatively worded 
questions and on positively worded question.  Table 55 shows the two negatively worded 
questions associated with the topic of confidentiality.  The mean response to participants’ 
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perspectives that “patients are concerned about the confidentiality of routine HIV testing” and 
that “it is difficult to provide the privacy needed for routine HIV testing” increased from 3.75 to 
4.0 (p=0.542), demonstrating a trend from neither agree or disagree to a response of disagree 
Table 55).  Table 56 shows the paired differences from the pre- and post-intervention survey.  
The mean difference between the pre- and post-intervention survey was -0.250 (Table 56).  
There was an improvement in the mean Likert scores from the pre-survey to the post-survey 
from a neutral a response of disagree. 
 Table 57 shows the positively worded question related to the topic of confidentiality.  
The mean response to participants’ perspectives that “patients are given HIV test results in a 
confidential, appropriate manner” increased from 4.8 to 5.0 (p=0.374), demonstrating a trend 
from agree to strongly agree (Table 57).  Table 58 shows the paired differences in the pre- and 
post-intervention surveys.  The mean difference from the pre-survey to the post-survey was -
0.200 (Table 58).  There was an improvement in the mean Likert scores trending to a response of 
strongly agree. 
 
Table 55. Topic: Confidentiality. Paired Sample General Statistics of Providers Who Completed 
the Pre- and Post-Intervention Survey (N=6). Negative Questions Reverse Coded: Section B- 
Strongly disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1. 
Confidentiality 
Questions: 
Section B. 9 “Patients are concerned about the confidentiality of routine HIV testing” 
Section B. 14 “It is difficult to provide the privacy needed for routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 3.75 0.935 0.381 
Post-survey 6 4.00 0.707 0.289 
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Table 56. Topic: Confidentiality (Negative Questions).  Pre-and Post-Intervention Analysis 
Using Two-Tailed, Paired Samples t-Test (N=6). 
Confidentiality 
Questions: 
Section B. 9 “Patients are concerned about the confidentiality of routine HIV testing” 
Section B. 14 “It is difficult to provide the privacy needed for routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.250 0.935 0.382 -1.232-0.732 -0.655 5 0.542 
 
 
Table 57. Topic: Confidentiality Paired Sample General Statistics of Providers Who Completed 
the Pre- and Post-Intervention Survey (N=5). Strongly Disagree=1, Disagree=2, Neither Agree 
or Disagree=3, Agree=4, Strongly Agree =5. (Positive Question).   
Confidentiality 
Question: 
Section C. 2 “Patients are given HIV test results in a confidential, appropriate manner” 
Group N Mean SD Standard Error Mean 
Pre- 5 4.8 0.447 0.200 
Post- 5 5.00 0.00 0.000 
 
 
Table 58. Topic: Confidentiality (Positive Question).  Pre-and Post-Intervention Analysis Using 
Two-Tailed, Paired Samples t-Test (N=5). 
Confidentiality 
Questions: 
Section C. 2 “Patients are given HIV test results in a confidential, appropriate manner” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.200 0.447 0.200 -0.755-0.355 -1.00 4 0.374 
 
 
The sixth topic evaluated is HIV-related stigma.  Table 59 shows the two negatively 
worded questions relating to the stigma associated with routine HIV screening.  The mean 
response to participants being “concerned that patients will be offended by being offered routine 
HIV testing and “patients being concerned or upset by routine HIV testing” increased from 3.25 
to 3.33 (p=0.849), demonstrating a slight trend from a neutral response towards a response of 
disagree (Table 59).  The mean difference of the pre- and post-survey responses was -0.083 
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(Table 60).  There was a slight improvement in the mean Likert scores from a neutral response to 
a response of disagree. 
 
Table 59. Topic: HIV-Related Stigma.  Paired Sample General Statistics of Providers Who 
Completed the Pre- and Post-Intervention Survey (N=6). Negative Survey Questions: Section B - 
Strongly disagree=5, Disagree=4, Neither Agree or Disagree= 3, Agree=2, Strongly Agree=1 
and Section C - Never=5, Rarely=4, About Half the Time=3, Most of the Time=2, or Almost 
Always or Always=1. 
HIV-Related Stigma 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 3.25 0.689 0.281 
Post-survey 6 3.33 0.816 0.333 
 
 
Table 60. Topic: HIV-Related Stigma.  Pre- and Post-Intervention Analysis Using Two-Tailed, 
Paired Samples t-Test (N=6). 
HIV-Related Stigma 
Questions: 
Section B. 3 “I am concerned that patients will be offended by being offered routine HIV 
testing” 
Section C. 4 “Patients are concerned or upset by routine HIV testing” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
-0.083 1.021 0.417 -1.154-0.988 -0.200 5 0.849 
 
The seventh topic evaluated in the pre-and post-survey is barriers and facilitators of 
routine HIV testing.  Table 61 shows the three negatively worded questions related to the topic 
of barriers and facilitators of routine HIV testing.  The mean response to participants being 
“concerned about cost and reimbursement for HIV testing,” concerned that “language barriers 
prevent some patients from receiving routine HIV testing,” and being concerned “that routine 
HIV testing will have a negative effect on patients’ opinions about our health care facility” 
increased from 3.08 to 3.00 (p=0.868), demonstrating a very slight trend down from a neutral 
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response towards a response closer to agree (Table 61).  Table 62 shows the paired differences in 
the pre- and post-survey responses for the topic on the barriers and facilitators of routine HIV 
testing.  The mean difference of the pre- and post-survey was 0.083 (Table 62).  There was not 
an improvement in the mean Likert scores as the responses were consistent in pre- and post-
survey responses. 
 Table 63 shows one positively worded question related to the topic of barriers and 
facilitators of routine HIV testing.  The mean response to participants’ perspective that they are 
“comfortable discussing routine HIV testing with patients” decreased slightly from 4.33 to 4.25 
(p=0.809), demonstrating a slight downward trend but consistent with an overall response of 
agree.  Table 64 shows the paired differences in the pre- and post-intervention surveys for the 
topic on the barriers and facilitators of routine HIV testing.  The mean difference from the pre-
survey to the post-survey was 0.083 (Table 64).  There was not an improvement in Likert scores 
as the responses in both the pre- and post-survey were consistent with the response of agree. 
 
Table 61. Topic: Barriers/Facilitators of Routine HIV Testing.  Paired Sample General Statistics 
of Providers Who Completed the Pre- and Post-Intervention Survey (N=6). Strongly 
Disagree=5, Disagree=4, Neither Agree or Disagree=3, Agree=2, Strongly agree =1 (Negative 
Questions).   
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 2 “I am concerned about cost and reimbursement for HIV testing” 
Section B. 5 “Language barriers prevent some patients from receiving routine HIV testing” 
Section B. 11 “Patients do not expect to be offered routine HIV testing” 
Section B. 12 “I am concerned that routine HIV testing will have a negative effect on 
patients’ opinions about our health care facility/clinic/emergency 
department/practice” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 3.08 0.701 0.286 
Post-survey 6 3.00 0.822 0.335 
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Table 62. Topic: Barriers/Facilitators of Routine HIV Testing (Negative Questions).  Pre-and 
Post-Intervention Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 2 “I am concerned about cost and reimbursement for HIV testing” 
Section B. 5 “Language barriers prevent some patients from receiving routine HIV 
testing” 
Section B. 12 “I am concerned that routine HIV testing will have a negative effect on 
patients’ opinions about our health care facility/clinic/emergency 
department/practice” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
0.083 1.169 0.477 -1.143-1.310 0.175 5 0.868 
 
 
Table 63. Topic: Barriers/Facilitators of Routine HIV Testing (Positive Question).  Paired 
Sample General Statistics of Providers Who Completed the Pre- and Post-Intervention Survey 
(N=6). Strongly Disagree=1, Disagree=2, Neither Agree or Disagree=3, Agree=4, Strongly 
agree=5 (Positive Question).    
Barriers/Facilitators of routine HIV testing 
Questions: 
Section B. 4 “I am comfortable discussing routine HIV testing with patients” 
Group N Mean SD Standard Error Mean 
Pre-survey 6 4.33 0.516 0.211 
Post-survey 6 4.25 0.612 0.250 
 
Table 64. Topic: Barriers/Facilitators of Routine HIV Testing (Positive Question).  Pre-and 
Post-Intervention Analysis Using Two-Tailed, Paired Samples t-Test (N=6). 
Barriers/Facilitators of Routine HIV Testing 
Questions: 
Section B. 4 “I am comfortable discussing routine HIV testing with patients” 
Mean SD Standard 
Error Mean 
95% CI t dF p 
0.083 0.801 0.327 -0.757-0.924 0.255 5 0.809 
 
The paired survey analysis of the providers showed little variation in the means for each 
topic for the pre- and post-survey responses, indicating the providers answered the questions 
related to each topic similarly on pre- and post-intervention survey.  The sample size was low, 
and; therefore, there is not enough data to determine the statistical significance of the findings.  
While there were some slight improvements in the means in many topics from the providers, 
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there was not a substantial increase in the survey response pre- and post-intervention.  It is likely 
that the providers’ responses to the surveys remained unchanged from the pre-intervention 
survey to the post-intervention survey. 
Post-Intervention Survey Short Answer Questions 
The post-intervention survey was the same as the pre-intervention survey, but also 
included three short-answer questions (Appendix 4 & 5).  Themes were derived from the 
responses.  Many responses were left blank even after participants were notified there was an 
extra page for short answers. 
 The first question of the short answer portion of the survey asks; “List any benefits or 
positive outcomes that have resulted from the implementation of routine HIV testing in your 
workplace.”  Themes from this response included patients being aware of their status and can 
given patients a piece of mind, there is greater awareness, and more patients are tested (Table 
65). 
 
Table 65. Post-Intervention Question 1: “List any benefits or positive outcomes that have 
resulted from the implementation of routine HIV testing in your workplace.” 
“Normalizing the test-by offering to everyone” 
“Increased awareness” 
“Not sure we have always done since I have worked here” 
“It addresses our quality indicators” 
“Early diagnosis” 
“None since I have no positives for > 1 year in my population” 
“Can help people know their status” 
“Greater awareness” 
“Gives patients a peace of mind of knowing their status” 
“More patients are tested” 
 
 The second question of the post-intervention survey asks; “List any problems or negative 
outcomes that have resulted from the implementation of routine HIV testing in your work 
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setting.”  Themes developed from this response were related to the time constraints with offering 
the test, patients being offended and no problems (Table 66).   
 
Table 66. Post-Intervention Question 2: “List any problems or negative outcomes that have 
resulted from the implementation of routine HIV testing in your work setting.” 
“I have not encountered any problems in implementing routine HIV testing” 
“Some patients do get offended” 
“ID clinic backed up so at times delay in initiation of therapy of positives” 
“Multiple administrative and paperwork tasks squeezed in a 15-minute visit” 
“Cost, time, and effort expended to get to “yes” on HIV testing, I do not order tests 
without telling the patient” 
 
 The final question of the post-intervention survey asks; “Share any other comments about 
this questionnaire or about the implementation of routine HIV testing in your work setting.”  
Many responses were left blank, but those that did respond asked about continued testing for 
their patients if they do not get positive results, one reported feeling pressured to offer screening 
because it is set as an EMR reminder and they consider their patient low risk (Table 67).   
 
Table 67. Post-Intervention Question 3: “Share any other comments about this questionnaire or 
about the implementation of routine HIV testing in your work setting.” 
“I do a lot of testing and do not get any positive test results.  Should I continue testing my 
patient population?” 
“I feel pressured to provide HIV testing for low risk patients due to the HIV testing being 
listed on my checklist for each patient on the EMR” 
“It’s a way/resource for patient teaching” 
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CHAPTER 7: DISCUSSION 
Summary 
Key Findings 
Primary care providers should be following ‘A’ and ‘B’ recommendation statements from 
the USPSTF and this is one attempt in process improvement project to implement routine HIV 
screening.  The purpose of this process improvement project was to increase routine HIV 
screening in a primary care setting.  While there have been some improvements in screening 
practices when comparing the data from 2017 to 2018, there is still room for improvement. 
 The Chronic Care Model was the framework used to guide this process improvement 
project as a way to use evidence-based and team-based approaches to improve routine HIV 
screening and improve health outcomes.  Table 3 discusses how the Chronic Care Model was 
utilized in this DNP project.  The Chronic Care Model guided this project by engaging the 
stakeholders, educating providers and staff on the HIV screening recommendations, supporting a 
team-based approach to routine HIV screening, utilizing the EMR to remind providers to 
offering screening, discussing with providers about educating patients on HIV screening 
recommendations; and allow for shared-decision making to accept or decline screening, and 
introduced local community resources to providers and staff for HIV management and treatment 
services. 
 One goal of the project was to increase the percentage of HIV screenings following the 
USPSTF 2013 HIV screening recommendations.  The overall percentage of screenings 
completed for the three months in 2018 combined was 25%, which was the same percentage as 
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the same three months in 2017.  The project did show an increase in the percentage of screenings 
completed per month in September (32%) and October 2018 (28%) when compared to 
September (28.5%) and October 2017 (27%) (Figure 4).  There was a decrease in the percentage 
of tests ordered in November 2018 (16.2%) when compared to November 2017 (22%) (Figure 
4).  The decreased percentage in November 2018 can be contributed to provider turnover in the 
practice, which included losing a provider champion. 
 The second goal of the project was to engage stakeholders and identify practice 
champions to support this project.  The practice administrator was the most engaged practice 
champion and helped to coordinate the information sessions and identify provider practice 
champions as well.  The first provider champion was a nurse practitioner with an interest in 
infectious disease, including HIV.  Unfortunately, this provider champion left the practice in 
mid-October during the intervention period.  A second provider champion identified was a 
physician who also had an interest in infectious disease, including HIV and was very vocal 
during the intervention about how he screens his patients routinely for HIV. 
 The third goal of this DNP project was to understand the provider and clinic staff 
personal perspectives about routine HIV screening using a pre- and post-intervention survey.  
The survey questions were not always straightforward and included both positively worded 
questions and negatively worded questions, which generated difficulty with the survey analysis.  
The sample size of participants was small (N=22) who completed both the the pre- and the post- 
intervention questionnaires.  The participants who completed the pre- and post-intervention 
questionnaires were those that were part of the intervention from the beginning and received the 
education on routine HIV screening.  The provider participants who completed a pre- and post-
survey was (N=6) which is included in the total number of participants (N=22) who completed a 
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pre- and post-intervention questionnaire.  The paired t-tests of all participants who completed 
both surveys (N=22) and the paired t-tests of the providers only, showed that there were positive 
trends in most of the seven topics discussed.  The seven topics include: the role of routine HIV 
testing in health care, routine HIV testing and the process of care, voluntary testing and consent, 
adequacy of patient information for testing, confidentiality, HIV-related stigma, and 
barriers/facilitators of routine HIV testing.  There was a slight negative trend in the topic of 
among the providers and all survey participants when asked the question “patients often feel like 
they have to accept routine HIV testing” for the topic of voluntary consent and testing. There 
was also a slight negative trend among the providers for the topic of barriers/facilitators to 
routine HIV testing when asked the question, “I am comfortable discussing routine HIV testing 
with patients.”  The mean Likert response was agree for both the pre- and post-survey, however, 
the slight decrease towards a neutral response can indicate providers are less comfortable 
discussing routine HIV testing than before the intervention.  With the education provided and the 
monthly check-ins by the principal investigator, this response was expected to have had a 
positive trend. Because of the sample sizes being small, it was unlikely to expect any statistical 
significance to be found.  It was also expected to see a change in the nurses and CMAs roles on 
routine HIV screening in the clinic, but because the clinic does not participate in staff-initiated 
screening, the CMAs continued to respond ‘no role in routine HIV testing’ on both the pre- and 
post-intervention survey.  The nurses, however, did have an improvement on the post-
intervention survey.  Their responses changed from ‘no role in routine HIV testing’ and ‘order 
entry or education patient and staff’ in the pre-intervention survey to ‘management or 
administrative role in routine HIV testing’, ‘supervise staff conducting HIV testing’, ‘teach other 
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health care providers or students about routine HIV testing’, ‘no role in routine HIV’, and 
‘educate patients’ (Table 8 & 9). 
 The fourth goal was to inform health care providers and clinic staff at the project site on 
the routine HIV screening recommendations, HIV statistics and the critical need to screen.  This 
goal was accomplished through the numerous information sessions held for the providers, the 
nurses and CMAs, and the front desk staff.  There was a total of 28 participants that attended the 
pre-intervention information sessions and 25 participants who attended the post-intervention 
information sessions.  The semi-structured interviews that occurred throughout the project also 
reminded participants of the screening recommendations and the need to be offering routine HIV 
screening to patients per the USPSTF 2013 recommendations.  The semi-structured interviews 
and information sessions also allowed for time for questions from the participants for the primary 
investigator. 
 The fifth goal was to identify barriers and process improvements for routine HIV 
screening.  The semi-structured interviews were used to discuss with the clinic staff and the 
nurse practitioners and physicians the barriers to HIV screening they encountered and ways to 
improve HIV screening for continual process improvement.  The principal investigator 
mentioned several times to the providers and the practice manager that the review of literature 
has shown an improvement in screening when the nurses or CMAs offer routine HIV screening 
when the patient is waiting in the room for the provider.  The providers did not have any 
comments about having nurses or the CMAs to begin the conversation about routine HIV 
screening; however, the practice manager made a comment that the CMAs and nurses would 
need more training to be able to discuss HIV screening with patients and all the providers would 
have to agree to allow the CMAs and nurses to offer screening.  The providers and manager did 
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not say ‘no’ to having nurses and CMAs offer the screening, but that it would take some time to 
get that process started.  The survey responses for the provider participants that completed both a 
pre- and post-intervention survey (N=6), had one topic that had a negative trend in Likert scores.  
This topic was about barriers/facilitators to routine HIV testing and question relating to this topic 
was “I am comfortable discussing routine HIV testing with patients.”  One explanation of this 
negative trend is, before the intervention period, the providers may not have been participating 
routine HIV screening, but using at-risk HIV screening interventions.  Since the discussion of 
routine HIV screening was started at this clinic, providers may not feel as comfortable discussing 
HIV screening with all patients, especially if they are patients they have established a rapport 
with and feel that offering routine HIV screening would not be appropriate for that patient. 
Another explanation would be providers did not respond consistently in the pre-survey and post-
survey, meaning they responded to the question with an answer of strongly agree on the pre-
survey and agree on the post-survey or vice versa, to make the post-survey mean Likert score 
slightly lower than the pre-survey. 
 The final goal of the project was to implement evidence-based interventions to improve 
HIV screening.  The Chronic Care Model helped to guide the project to meet this goal.  The 
clinic’s EMR already had a HIV screening reminder embedded in the patient’s medical record 
under health maintenance using the 2013 USPSTF screening recommendations.  Through 
academic detailing, the nurse practitioners and physicians were educated on the specific 
diagnosis codes used for office visits that should have a HIV test ordered with them, such as, 
physical examinations, STD or STI visits or annual examinations.  The providers were also 
educated on the process for ordering an HIV test to maintain that the decision for a patient to 
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accept testing is based on shared-decision making and that the patient has the opportunity to opt-
out if they decline to be screened for HIV. 
Strengths 
The practice manager played a critical role in participant recruitment and identifying 
practice champions.  The clinic had between 25 to 30 staff members, including the physicians 
and nurse practitioners.  The practice manager assisted in arranging meetings when the most 
participants can attend, otherwise, the sample size could potentially have been much smaller.  
The nurse practitioners and physicians, as well as the rest of the clinic staff accepted the project 
and generally were interested in learning about HIV in their community.  There were two 
provider practice champions identified prior to the start of the project that were the two most 
interested in HIV and most engaged during information sessions.  The practice champions 
participated in the information sessions and talked about their screening practices and the 
importance of routine screening at their clinic. 
 Another strength of this project was the EMR reminder for HIV screening already in 
place.  This reminder had a link to the USPSTF recommendations and automatically appears in 
the chart when a patient turns 15 years old and remains there until it has been completed or until 
the patient is 66 years old.  The nurse practitioners, physicians, nurses and CMAs each have 
access to the reminder and is highlighted in pink when an item has not been completed or is 
overdue.  The EMR reminder allows providers an opportunity to offer screening when they are 
reading the patient’s medical record and can visualize that an HIV test is due rather than the 
provider having to rely on memory as to what screenings need to be completed on each patient. 
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Interpretation 
The HIV Screening Laboratory Tests 
There was not an overall increase in the percentage of HIV screening tests ordered from 
2017 to 2018 during the combined months of September, October and November.   Twenty-five 
percent of clinic encounters had a HIV test ordered in both 2017 and 2018 despite the increase in 
the number of encounters in 2018.   The number of encounters increased by 5.66% from 2017 to 
2018 during the same three months.  In 2017, there was a steady number of HIV tests ordered in 
the months of September (N=142), October (N=155) and November (N=130).  However, in 
2018, there was a significant decline in the number of HIV tests ordered during the month of 
November (N=96).  September and October 2018 had 173 and 174 HIV tests respectively, 
ordered.  The decline in HIV tests ordered may be contributed to the provider turnover that 
started mid-October into mid-November.  One key provider that left the practice mid-October 
was also one of the practice champions for the project who had an interest in HIV and infectious 
disease and was more likely to screening patients for HIV than other providers in the clinic. 
Age Data 
There was an equal distribution of tests ordered by age group in 2018 when compared 
with the 2017 baseline data (Figure 4).  In 2018, there were more patients over the age of 65 who 
were ordered an HIV test from 34 in 2017 to 52 in 2018.  It is unknown if patients over the age 
of 65 and over the age of the 2013 USPSTF screening recommendations that if these patients 
were screened for HIV or if it was because they were considered high-risk and an HIV test was 
ordered for diagnostic purposes.  Patients who were in the 60 to 65 years old age group had 
increase in HIV tests ordered in 2018 by 28.7% from 2017.  There was a slight decrease in the 
number of HIV tests ordered for the age group of 50 to 59 from 156 in 2017 to 130 in 2018.  The 
remaining age groups 40-49, 30-39, 20-29 remained stable from 2017 to 2018 with slight 
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fluctuations.  The clinic typically does not see patients under 18 years old, however, there was 
only one test ordered in the age group of 15 to 19 in 2017 and no tests ordered in 2018.  The age 
group of 20-29 years old accounts for 41% of prevalent cases in North Carolina as of 2017; 
however, the results of this project are not typical for this age group as the clinic’s average age of 
their population is 55 to 60 years old. 
Other Demographic Data 
Despite the patient population are 55% women and 45% men, in both 2017 and 2018; 
men were ordered an HIV test more often than women.  However, the number of tests ordered 
for each sex remained largely unchanged from 2017 to 2018.  Men who have sex with men 
(MSM) are at a higher risk for HIV infection.  The fact that providers at the clinic are screening 
more men leaves the chance that patients who are MSM are being screening whether or not they 
have identified their sexuality to their provider. 
The HIV tests ordered did not have much of a variance by race (Figure 6).  There were 
more White or Caucasian patients ordered an HIV test in both 2017 and 2018 out of all races in 
both years.  Black or African American patients were the second most patient population who 
were ordered an HIV test in both years and the number of patients largely remained unchanged 
when compared with 2017 and 2018 data.  The clinic’s patient population consists of 
approximately 60% White or Caucasian patients and 30% Black or African American.  The 
clinic is screening patients between both Black and African American and White or Caucasian 
races evenly during the intervention period that correlates with their patient population.  The 
other races also remained stable from 2017 to 2018 for the number of HIV tests ordered.  The 
clinic is screening patients for HIV based on the demographics of their clinic, which is majority 
White or Caucasian with Black or African American coming in second; however, the 
demographics of the clinic are not consistent with the at-risk population in the south. 
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The population included in this project are not typical of the Guilford County population 
in terms of those patients who are uninsured or are on Medicaid as a primary insurance carrier.  
This clinic is also not a Federally Qualified Health Center (FQHC), therefore, results of this 
project in terms of the percentage of screenings ordered is most likely much less than if this 
project was completed at an FQHC.  Black or African Americans have been identified as the 
population with higher rates of HIV infections nationwide; however, this project shows that the 
clinic sees a significant increase in White or Caucasian patients than Black or African American 
patients, which if the clinic saw an inverse number of Black or African American patients, it is 
possible the number of screenings would be increased. 
Pre-Intervention Survey 
The pre-intervention survey was distributed to all participants during the months of 
August, September and October of 2018 (Appendix 4).  There were 28 participants in the pre-
intervention survey.  Participants were asked to identify their professional role in the clinic and 
their role in routine HIV screening at the clinic at the time the survey was distributed.  The 
majority of the non-provider staff members (front desk staff, CMA, nurse, manager) reported 
they did not have any role in HIV screening or simply left that response blank.   
Post-Intervention Survey 
The post-intervention survey was distributed to participants in January and February 
2019 (Appendix 4 & 5).  There were a total of 25 participants in the post-survey.  The front-desk 
staff and CMAs reported they do not play a role in routine HIV screening.  However, there was 
an increase in the nurse’s responses from the pre- to post-intervention survey to having more of a 
role in routine HIV screening through management or administrative roles, supervising others, 
teaching about routine HIV testing to students and providers, and educating patients (Table 9). 
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Pre- and Post-Intervention Survey Evaluation 
There were 28 participants who completed the pre-intervention survey and 25 
participants who completed the post-intervention survey, which included the nurse practitioners, 
physicians, nurses, CMAs, manager, and front desk staff.  Despite the turnover of staff members, 
a total of six providers out of the nine that started at the pre-intervention survey completed both a 
pre- and post-intervention survey.  Since the sample size was small, statistical significance could 
not be determined.  
Out of the seven topics analyzed for the surveys, in the group statistic analyses. which 
includes all those participants who completed a pre-intervention survey and the participants that 
completed a post-intervention survey, six of the topics saw an increase in the mean score of the 
survey responses.  While there was not a substantial increase in the mean Likert scores, there was 
enough of an increase to understanding that participants’ perspectives may have changed since 
the start of the intervention. 
The survey responses could be paired pre- to post-intervention because of the confidential 
identifier assigned to the participants at the start of the project.  The paired responses also 
included the nurse practitioners and physician surveys.  Again, because the sample size was 
small, statistical significance could not be determined.  However, with the paired survey 
responses, all topics had mean Likert scores that increased slightly, with the exception of the 
negatively worded questions for the topic of voluntary testing and consent (Table 28).  While 
there was no substantial change in the mean (3.50 pre-survey to 3.35 post-survey), most of the 
responses to this question were neutral responses. 
The survey responses of the providers were also isolated from the rest of the survey 
participants’ analysis because they were the main focus of this project.  The providers had slight 
improvements in the trends of the mean Likert scores in most topics, except for the negative 
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questions for the topic of voluntary testing and consent and the positive question for 
barriers/facilitators of routine HIV testing.  Although there was not a substantial decrease in the 
mean scores for these topic, the providers generally responded with a neutral answer to the topic 
of voluntary testing and consent and responded with “agree” to the topic of barriers/facilitators of 
routine HIV testing. 
This survey did show some changes in the perspectives of the participants related to 
routine HIV screening in the clinic.  There was a small sample size that completed the surveys 
and even, then some of the participants answered some questions with a response of “don’t 
know” or “not applicable” leaving those participants out of the analysis for that particular 
question, driving the sample size down even further.  It is possible there may be other surveys 
available that would be better fit participants attitudes, skills and knowledge of routine HIV 
screening that is more manageable and easier to analyze. 
Focus Groups   
There were not any formal times for focus groups at this practice, as the practice was 
very busy, and providers typically worked through lunch or held staff meetings during lunch.  
There were several opportunities throughout the intervention when the principal investigator 
visited the practice on different days throughout each month during the intervention to discuss 
HIV screening and report any issues or barriers noted related to HIV screening.  This was also a 
time when participants can ask questions about HIV screening. 
In August at the provider meeting, one provider openly spoke about how he screens most 
of his patients for HIV and about his personal interest in infectious diseases, especially HIV.  He 
was knowledgeable about the screening recommendations prior to the start of the project, but 
was unaware of some of the resources in the community, as well as the providers should be 
asking patients whether or not they want to be tested for HIV at their clinic visit to allow for 
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‘opt-out’ screening.  This same provider also made the suggestion for the Medicare wellness 
nurse to be able to order the HIV test when Medicare patients come in to see her for their annual 
wellness visit.  All of the providers agreed that they have not experienced a lot of negativity from 
patients when HIV screening was offered, but also reported they don’t always have time to ask 
or think about asking their patients, especially their patients they have known for a long period of 
time that they don’t feel are at risk for becoming infected with HIV.  
In September, at the CMA and nurse meeting, many staff members at this meeting did 
not have much to say about HIV screening.  According to their survey responses, the CMAs 
reported they have no role in HIV screening at this practice (Table 8).  The CMAs and nurses 
were given the same handouts as the providers, which included local resources in the community 
for HIV-related services and discussed how the review of literature has shown an increase in 
acceptance to screening by patients when the CMA or nurse begins the conversation at the 
beginning of the appointment.  During this meeting, the Medicare wellness nurse also stated that 
she would look into ordering HIV screening when patients come for their wellness visit.  
However, the USPSTF 2013 recommendations state to screen patients over 65 years of age if 
they are at an increased risk for HIV and do not recommend routinely screening if over 65 with 
no risk.  Many patients receiving Medicare benefits at this clinic are over the age of 65 years old.  
Also, during September there were several conversations with providers and CMAs about 
the barriers or issues with screening.  One provider said that many of his patients do not accept 
screening because they feel they are not at risk for HIV infection.  Another provider stated she 
has oral swabs that she personally purchased if she suspects a patient has an acute infection or is 
afraid of needle sticks.  The principal investigator also asked providers if they are educating the 
patients on the screening recommendations, which two providers said they do not educate them.   
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One provider said she simply does not always have time to address HIV screening with patients 
because of the number of other complex problems they have to discuss.  The principal 
investigator informed providers that they should be informing patients about the 
recommendations for routine HIV screening and why they are asking the patients if they would 
like an HIV test at their visit.  The principal investigator also advised providers to display posters 
that advertise routine HIV screening in their exam rooms to notify patients that the clinic if 
offering routine HIV screening to patients.  When walking around the office during this month, 
there were no signs or brochures on display in the exam rooms that advertised routine HIV 
screening.  The principal investigator asked the practice manager about hanging up posters and 
putting brochures on display, but stated that it was up to the provider to display these items.  A 
pocket guide was created and distributed to the nurse practitioners and physicians during the 
month of September that reminded them of the USPSTF 2013 recommendations for routine HIV 
screening as well as common diagnosis codes used when screening for HIV (Appendix 3). 
In October, the principal investigator met with the front desk staff to discuss routine HIV 
screening and educate them on the recommendations.  This group also reported they have no role 
in HIV screening and most were not aware of the screening recommendations.  One receptionist 
was unaware about Guilford County having a high incidence and prevalence for HIV.  The front 
desk staff were all given the same handouts as the providers (Appendix 2) and discussed if 
patients ask about HIV screening, but wish to do it outside of the practice, they can refer them to 
the local community resources that were provided in their handouts. 
During the month of October, three CMAs and one provider met with the principal 
investigator to follow up on HIV screening at the clinic and had a general conversation about 
routine HIV screening.  All four informed the principal investigator that there were no problems 
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with offering screening or patients problems related to screening.  The provider reported that 
patients often do not accept screening because they have had done once already or do not feel 
like they are at risk at this time.  The principal investigator also asked the provider if they felt if 
the CMAs began the conversation of asking the patients when they are roomed if they would like 
an HIV screening test before seeing the provider.  The provider said it would be a good idea, but 
he added that all the providers would have to be on-board to having the CMAs offering the 
screening and the CMAs would need more education to feel comfortable with discussing HIV 
screening with the patients.  The principal investigator asked the provider if he explained to 
patients who declined HIV screening why screening is offered; and he said he did not explain it 
to patients.  The principal investigator advised this provider that a brief description of the routine 
HIV screening recommendations to patients may help inform the patient to make a better 
decision about whether to accept or decline the screening. 
November was the final month for data to be collected on the project.  The principal 
investigator rounded twice during the month on providers and staff about the routine HIV 
screening.  The principal investigator had been at the clinic more times in September and 
October, which could have also led to a decrease in the number of HIV tests ordered.  Two 
providers left during this month and the new nurse practitioner continued to see a low volume of 
patients, about six to seven per day when compared to experienced providers who are seeing 
about 20 to 22 patients per day.  The providers continued to report no issues with the project and 
had similar responses to previous months when asked about HIV screening.  One provider stated 
that most of his patients accept the HIV screening because he informs them that it is a part of 
their annual physical and insurance pays for it. This provider also mentioned that his patients 
have been seeing him for several years and he has established a good rapport with his patient 
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population.  The CMAs the principal investigator met with, continue to state they do not have an 
active role in offering HIV screening at this time, but states they would be willing to have a role 
in routine HIV screening if the providers agreed to allow the opportunity to start the process. 
Saturday December 1, 2018 was World AIDS Day.  The principal investigator visited the 
clinic on Friday November 30th to promote World AIDS Day, give handouts, and discuss the 
theme of the event, which was “Know Your Status” and how it relates to the project (Appendix 
8).  Since it was a Friday, many providers were off or worked a half-day in the morning and were 
gone before the principal investigator arrived at the clinic.  There were two providers available to 
talk with; both were unaware that World AIDS Day was on annually on December 1st.  One 
provider also talked about PrEP and how she has started a few patients on PrEP recently.  The 
principal investigator informed the providers that November 30th was the last day for data to be 
collected and that providers should continue offering routine HIV screening despite the fact that 
data would no longer be collected for this project after November. 
In January 2019, the principal investigator met with all the providers of the clinic and the 
CMAs in two separate meetings.  During the provider meeting, one only provider questioned 
about when they should stop screening patients.  The principal investigator informed him that the 
guidelines currently state to screen patients ages 15 to 65 years old once, but according to the 
CDC guidelines, if the prevalence of HIV is less than 0.1% in a population then risk-based 
screening can be initiated (CDC, 2006; USPSTF, 2013).  Guilford County prevalence is over 
0.1%.  The principal investigator asked providers about why they were ordering an HIV test on 
patients over the age of 65.  One provider reported he orders them because the insurance will pay 
for it and other providers agreed.  Providers did not offer any other explanation as to why they 
order an HIV test on patients over 65 besides for screening or diagnostic purposes.  It is not 
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known if any of the HIV tests ordered in 2017 or 2018 in patients over the age of 65 years old 
were screening tests or diagnostic tests.  No other providers had any negative or positive 
feedback about the project and did not have any comment on whether or not CMAs or nurses 
should initiate offering HIV screening to patients when they are waiting in the examination 
room. 
During the CMA and nurse meeting, participants did not engage in conversation about 
the project or HIV screening in general.  The Medicare wellness nurse was present during this 
meeting and reported that she is unable to order an HIV test during a Medicare wellness visit 
because the patient still needs to see the provider for labs to be ordered for billing purposes.  The 
Medicare wellness nurse is also a health coach and reported that she does have a conversation 
with patients about routine HIV screening who are 65 years old or younger, and has tried to 
make sure she does it with all patients at every visit since the project started.  This nurse, 
however, does not have the ability to order labs at this visit, but initiates the conversation for 
when the patient sees their provider it can be ordered then.  The principal investigator again 
informed the CMAs and nurses that if they offer HIV screening when the patient is waiting in the 
room, this may help capture more patients rather than waiting for the provider to ask.  The 
CMAs and nurses again reported that it would be up to the providers to agree to make that 
change, but are willing to have an opportunity to offer screening if trained properly and the 
providers are agreeable. 
Comparison to Other Studies 
As evidenced by the review of literature in this paper, there is a lack of rigorous studies 
on routine HIV screening practices in primary care settings.  One study completed in 2010 at 
major health system in Cleveland, Ohio, added an electronic medical record reminder to the 
health maintenance list to their existing EMR in July of 2010 (Avery et al., 2014).  The study 
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(Avery et al., 2014) utilized the CDC’s 2006 recommendations for routine HIV screening since 
the study occurred before the 2013 UPSTF recommendations were released.  The investigators 
targeted several clinics that were located in areas where HIV prevalence and incidence were high 
and conducted information sessions with stakeholders about screening practices and local HIV 
statistics (Avery et al., 2014).  The project investigators delved into patient medical records 
looking at screening trends and missed opportunities for screening.  The project team looked at 
data from January 2008 to December 2011, using 2008 as the baseline data (Avery et al., 2014).  
The study showed the there was an increase in patients screened for HIV once the reminder was 
placed in the EMR that had never been screened for HIV before the reminder (Avery et al., 
2014).  The study also mentions the integration of the reminder in the EMR helps to achieve the 
Strategic Plan from the CDC to reduce new infections and increase the number of patients who 
know their HIV status.  This study did not survey the stakeholders on their perceptions of routine 
HIV screening and used an interrupted time series to analyze the data.  This study (Avery et al., 
2014) and this DNP project were both process improvement projects aimed to improve the 
percentage of patients screened for HIV while working towards the CDC’s Strategic Plan to 
increase the number of patients who know their HIV status to at least 90%.  The reminder used 
in the study completed by Avery et al., 2014 is similar to the reminder used at the project site 
where this DNP project took place; however, the reminder has been updated since 2010 and does 
not have the same functionality as the study completed in Ohio did.  One difference between the 
study completed in Ohio and this DNP project is, the DNP principal investigator spent time 
educating the providers, nurses, CMAs, and front desk staff about the screening 
recommendations, and alternative ways to increase the number of patients screened, such 
through nurse or CMA initiated screening, and also surveyed their perspectives on routine HIV 
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screening.  The Avery et al., 2014 study did some education prior to the intervention, but did not 
continue to educate on routine HIV screening, but simply created a passive EMR reminder to 
screen patients for HIV.  The Avery et al., 2014 study did show improvements in HIV screening 
percentages than before the EMR reminder was created, but there is no measurement to if there 
was increased knowledge regarding routine HIV screening recommendations.  
Limitations 
There were several limitations to this process improvement project.  The project 
addressed one primary care practice located in Guilford County North Carolina.  While this 
primary care practice is affiliated with a prominent health care system in the region, the 
providers at each clinic practice medicine differently.  Despite the fact that this health system 
automatically has HIV screening under the health maintenance list when a patient turns 15 years 
old, the EMR reminder does not mean all providers are offering screening or addressing this item 
on the list.  There currently is not a quality measure or indicator that is tracked at this clinic to 
see who is offering HIV screening and who is not or how often HIV screening is being 
completed. 
Data Collection  
Because this is the first-time data have been analyzed for HIV screening in this practice, 
there was difficulty obtaining the data.  When the idea of this project was conceived the original 
plan was to obtain HIV screening data on specific diagnosis codes (Table 5), as these diagnosis 
codes are most often associated with physical examinations, or STD or STI screening visits.  
However, because of the nature of how the actual HIV test was ordered by providers, using the 
type of encounter (Table 7) was the best way to get the number of HIV tests actually ordered per 
the IT analyst who obtained the data.  Unfortunately, obtaining the data by encounter type does 
not disclose if the lab test was ordered diagnostically or if it was a screening HIV test.  The other 
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item the results do not identify is if the HIV test was actually performed.  Most patients that 
come in to the clinic for a physical examination or annual wellness visit have blood work ordered 
during the visit or before the visit.  The data received from the IT department only conveys if the 
HIV test was actually ordered in Epic, not that the lab performed the test.  Also, it is not known 
if the patients who did not have an HIV test ordered already had one completed or possibly have 
a diagnosis of HIV or AIDS.  Additionally, it is uncertain if those above 65 years old were “at 
risk” and/or had a screening or diagnostic test completed. 
Staff and Provider Changes 
Throughout the intervention period there were several significant provider changes.  
At the start of the project in August 2018, the provider meeting was missing one 
provider.  This provider was on a leave of absence until mid-September. However, this provider 
who was on leave of absence did meet with the principal investigator upon their return to inform 
them of the project, gave them the handouts from the pre-intervention information session and 
had the provider complete a pre-intervention survey. 
In October, one provider, a nurse practitioner, who had knowledge of routine HIV 
screening prior to the start of the project and was considered one of the practice champions for 
the project, left the practice in the middle of October to specialize in Infectious Disease.  Also, 
during this month, a new graduate nurse practitioner joined the practice after the other nurse 
practitioner left.  The practice champion that left, did assist the principal investigator with 
informing the new nurse practitioner of the project and had the new provider complete the pre-
intervention survey before they started seeing patients at the clinic.  The new graduate nurse 
practitioner started off seeing about four to five patients per day which were not always 
physicals, thus leading to the possibility that a decreased number of patients were coming into 
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the clinic after they started since they were seeing approximately 10-12 less patients per day 
leading to less HIV screenings being completed. 
In November, a nurse practitioner and physician left the practice for another primary care 
clinic that is affiliated with the same health system.  Also, throughout the project there were 
several nurses and CMAs that joined or left the practice. 
To address the limitation of provider and staff turnover that occurred during the project, 
the principal investigator worked with the practice manager to attempt to get participants to 
complete a post-intervention survey before leaving the practice, especially if they completed a 
pre-intervention survey. 
Epic Update 
On Sunday November 4, 2018, the Epic software was upgraded from Epic version 2017 
to Epic version 2018.  This brought changes in several areas of the EMR.  Providers and staff 
were notified of the upgrade in September of 2018 and given handouts of the changes to the 
ambulatory care EMR and were also offered training classes from the health system to prepare 
for the upgrade.  The health maintenance list was changed after the upgrade.  The HIV screening 
reminder remained on the health maintenance list; however, it was not as easy to modify as it 
was in the previous version of Epic.  Previously, providers were able to modify HIV screening to 
be offered yearly instead of just one time, but with the new version, providers could not change 
the frequency of HIV screening.  This could potentially be a problem especially, if a provider is 
caring for a patient that is considered high-risk for becoming infected with HIV and cannot 
modify the reminder to prompt them to offer an HIV screening on a more frequent basis.  
Another change in the health maintenance list was once an HIV test was completed, it was 
moved to a section below other health maintenance list items and listed as ‘inactive”.  Once it 
was listed as inactive, it could not be re-activated.  Even though the HIV screening was listed as 
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inactive, if repeated tests are to be completed the date will appear next to the word “HIV 
screening” with a hyperlink attached to the date with the result of the HIV test.  
The principal investigator was notified of the Epic upgrade in September 2018 and 
encouraged the nurse practitioners, physicians and other clinic staff to view the practice 
environment of the upgraded system to get an idea of what the changes were going to be like.  
The principal investigator also practiced with using the health maintenance list and could 
visualize how the Epic upgrade would affect the HIV screening reminder.  This information was 
presented to the providers and clinic staff at the follow-up information session meeting in 
January and February 2019. 
The Epic upgrade also delayed data collection, as the IT department was busy with 
preparing the entire health system for the upgrade and troubleshooting problems after the 
upgrade.  The data analyst who compiled the data report also wanted to wait until after 
November 30th to get all the results at the same time to keep in one document.  The practice 
manager was responsible for obtaining the data because the principal investigator did not have 
access to the patient’s medical records.  The principal investigator requested the data to start 
being collected in September of 2018; however, the practice manager was unable to decipher 
how to obtain the data from the EMR without having to submit a request to the IT department.  
Unfortunately, the IT analyst that obtains data from the EMR from the practice site, preferred to 
wait until after the upgrade in November and to compile all the data at one time for 2017 and 
2018.  This delay in data collection each month prevented the principal investigator from being 
able to give feedback to providers and staff throughout the implementation process. 
Principal Investigator Out of Clinic 
The principal investigator worked closely with the nurse practitioner who was identified a 
practice champion at the start of the project.  This was the same provider who left in the middle 
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of October to pursue a different career path.  Once this provider was out of the clinic, a new 
provider practice champion was identified; however, this provider was not in the clinic often 
when the principal investigator would be in the clinic.  The principal investigator also had other 
commitments for school and work, which did not allow for as much time to be spent in the clinic 
especially during the month of November 2018.  The lack of the principal investigator present 
more often could have contributed to a lower percentage of screenings completed during the 
month of November 2018.  The principal investigator was at the clinic on the last day of the 
intervention on November 30, 2018 to discuss World AIDS Day and provide information related 
to World AIDS Day and how it relates to the project and provided an update on the upcoming 
revisions that have been proposed to the recommendations for routine HIV screening from the 
USPSTF (Appendix 8). 
Natural Disasters 
In September 2018, Hurricane Florence affected North Carolina.  The clinic itself 
remained opened during this time, but patients did cancel and re-schedule appointments during 
the time the hurricane hit in anticipation of in-climate weather.  One of the providers did take off 
the entire week around the time when Hurricane Florence was anticipated to hit to prepare his 
beach house, therefore, those patients had to cancel or be re-scheduled for another time. 
 In October 2018, another hurricane affected North Carolina, Hurricane Michael.  The 
principal investigator was at the clinic on October 11th when the rains and flooding hit Guilford 
County.  Fortunately for the clinic, the power did not go out, however, many patients did cancel 
or did not show up for their appointments the day Hurricane Michael hit and the day after.  Many 
residents throughout Guilford County including the principal investigator were without power 
for several days. 
   
107 
 These natural disasters while they did not cause as near as much destruction as the coastal 
areas and areas east of Guilford County, the clinic did have some effect.  Patients that did not 
show up for their visits to clinic may have missed their opportunities to be offered an HIV test 
which may have impacted the results of this project.  However, the number of screenings 
completed in September and October were about the same despite the natural disasters and the 
change in providers. 
Conclusions 
Sustainability 
One recommendation to the clinic is to have the CMAs and nurses begin the discussion 
of routine HIV screening when the patient is coming in for a physical or STD or STI visit while 
waiting for the provider in the exam room.  Additionally, standing orders for screening tests 
could be in place for RNs or CMAs by the medical director to ease the burden off the providers.  
There have been several studies published that report improvement in screening rates by utilizing 
nurses and CMAs to offer screening.  One study done through the VA saw a 70% increase in 
HIV testing when a nurse initiated the testing (Knapp et al., 2011).  While the patient is waiting 
to see the provider, the CMA or nurse is getting the patient’s vital signs, updating current 
medications, and verifying allergies.  A conversation that is often occurring between the patient 
and the CMA or nurse while the patient is waiting in the exam room, is the immunizations that 
are due at the time of the visit.  The immunizations that are due are listed under the health 
maintenance section of the EMR where the HIV screening reminder is located.  The CMA or 
nurse can inform the patient that they have not had an HIV screening before and that it is 
recommended by the USPSTF to be screened at least once between the ages 15 to 65 years old.  
If a patient agrees or declines, the CMA or nurse can mark that the patient declined the screening 
and postpone the screening to be asked at their next physical or appropriate visit.  If the patient 
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accepts to have an HIV test during the visit, the CMA or nurse can inform the provider to order 
the test to be collected in the lab.  By having the CMA or nurse start the conversation about HIV 
screening, this gives the provider more time to complete the physical and focus on other health 
issues and possibly reach more patients if providers are forgetting to offer the screening. 
 This DNP project will also be presented to the Nursing Research Council (NRC) at Cone 
Health during one of their monthly meetings.  This will be an opportunity to increase the 
awareness of routine HIV screening and the importance for providers to offer screening to 
patients who present to primary care clinics for physical examinations, annual visits, and STD or 
STI screening visits.  There currently is not a quality measure for routine HIV screening for this 
health system, therefore, by encouraging clinics to monitor the number of HIV screenings being 
done may increase the awareness to offer routine HIV screenings more consistently. 
Implications for Practice 
There are several clinical implications for practice that can be made from this DNP 
project.  The most important implication is to increase the knowledge of the routine HIV 
screening recommendations among physicians, advance practice providers (APPs), nurses, 
CMAs, certified nursing assistants (CNAs), and other health care workers.  The impact of 
increased knowledge of these screening recommendations could potentially help to further 
reduce HIV transmission to among patients with an unknown serostatus and also meet the CDC’s 
Strategic Plan to increase the percentage of persons living with HIV who know their serostatus to 
at least 90% (CDC, 2017c). 
Doctor of Nursing Practice students are educated on the eight Essentials of Doctoral 
Education for Advanced Nursing Practice (American Association of Colleges of Nursing 
[AACN], 2006).  The seventh essential; “Clinical Prevention and Population Health for 
Improving the Nation’s Health” implies that as doctoral prepared advance practice providers, our 
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focus is on health promotion and prevention of disease by leading the integration of evidence-
based recommendations, such as the USPSTF 2013 HIV screening recommendations into their 
daily practice and educating others to do the same (AACN, 2016).  Advanced practice providers 
and physicians alike should be practicing to the full extent of their license and should be 
following the USPSTF ‘A’ and ‘B’ recommendations for preventive services. 
Suggested Next Steps 
There is a need for further research in ways to improve the number of HIV tests ordered 
for routine HIV screening.  There continues to be a significant amount of stigma related to HIV 
and AIDS despite the research and development in treatments worldwide.  The Southeastern 
states continue to be burdened by the HIV/AIDS epidemic because of the high incidence and 
prevalence in certain counties.  Lack of access to care and untimely linkage of care for positive 
diagnoses leads to continued transmission of HIV.  All health care settings should be offering 
routine HIV screening to patients per the 2013 USPSTF recommendations to make certain that 
all patients are aware of their HIV status.  Research should continue to focus on ways to reduce 
HIV-related stigma, educating providers on HIV screening recommendations, and addressing 
and preventing barriers to routine HIV screening.
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APPENDIX 1: CONE HEALTH PATIENT CONSENT FORM 

























































































Cone Health Regional Center for Infectious Disease 
 
Contact Information: 
301 East Wendover Avenue Suite 111 





Monday-Thursday 8:30am – 5pm 
Friday 9am-5pm 
Closed daily for lunch 12:30pm-1:30pm 
 
 
Information for HIV Patients 
• Referral required by PCP 
• Received funding from Ryan White Program parts B, C, and D 
• Financial Counselor and Social Worker available 
• First appointment is with the New Patient Nurse with a follow up appointment a few 
weeks later with the provider 
• Lab work will be collected on first appointment with the nurse prior to seeing 
provider 









40 Duke Medicine Circle 
Clinic 1K 
Durham, NC 27710 
 







Monday through Thursday 8:00 am – 5:30pm 
Friday 8:00 am – 12:00 pm 
Closed Saturday and Sunday 
 
Services: 
• HIV patients do not require a referral 
• Can be seen within 48 hours of phone call 
• First appointment is with a social worker to assess needs and provide 
resources for access to medical care and necessary medications 
• Team-based approach: includes providers, nurses, social workers, 
counselors for mental health and substance abuse, pharmacists, and 
finance resource managers 
• Pharmacist is on-site for medication management  
• Can provide primary care services or coordinate care with patient’s 
established primary care provider 
• Clinical trials 











122 North Elm Street 
Suite 1000 





Wednesday 12:00 pm – 6:00 pm or by appointment 
 
Services: 
• Counseling services 
• Confidential results in 10-14 days 











The University of North Carolina at Chapel Hill 
 
UNC Infectious Disease Clinic 
 
Address: 
First Floor Memorial Hospital 
101 Manning Drive 










 Monday through Friday 8:30 am- 5:00 pm 
 
Walk-In (for established patients with HIV only) 
 Monday, Tuesday, Thursday Friday 8:30 am – 12:00 pm 
 
Services: 
• Ryan White funding available 
• Access to clinical trials through the Global HIV Prevention and 
Treatment Clinical Trials Unit 
• Primary care services available for patients without a PCP or coordinate 
services with existing PCP 












Wake Forest Baptist Medical Center 
 





Richard Janeway Clinical Sciences Tower 
Bowman Gray Campus 
7th Floor Clinic 
300 Medical Center Boulevard 
Winston-Salem, NC 27157 
 
Clinic appointments: 336-716-2700 
Health on-call: 336-716-2255 
 
Services: 
• Ryan White funding available 
• HIV/AIDS specialty medicine, nursing and pharmacy care 
• Social work services 
• Prescription assistance 
• Oral health care 
• Assist with referrals to regional HIV/AIDS service organizations 
• Access to Wake Forest Baptist Medical Center medical specialties 
• All patients who are HIV positive receive financial counseling 
• Comprehensive primary care services to patients who are HIV positive 
• Patients can be insured or uninsured 











































2013 United States Preventive Services Task Force 
Recommendation for Routine HIV Screening  
Populati
on 







The USPSTF recommends 
that clinicians screen for 
HIV infection in adolescents 
and adults aged 15 to 65 
years. Younger adolescents 
and older adults who are at 
















































List of ICD-10 Codes and the CPT Code for Routine 
HIV Screening 
Z11.3 Encounter for screening for infections with 
a predominantly sexual mode of 
transmission 
Z11.4 Encounter for screening for human 
immunodeficiency virus 
Z00.00 Encounter for general adult medical exam 
without abnormal findings 
Z00.01 Encounter for general adult medical 
examination with abnormal findings 
Z01.411 Encounter for gynecological exam 
(general) (routine) with abnormal findings 
Z01.419 Encounter for gynecological exam 
(general) (routine) without abnormal 
findings 
Z20.2 Contact with and (suspected) exposure to 
infections with a predominantly sexual 
mode of transmission 
Z20.6 Contact with and (suspected) exposure to 
human immunodeficiency virus [HIV] 





APPENDIX 4: SURVEY FOR PROVIDERS AND STAFF 
Pre- and Post- Intervention Survey 
Questionnaire ID Number____________  
Questionnaire for Health Care Providers and Staff 
 
Instructions:  
This survey is being done to obtain the perspectives of health care providers and staff about routine HIV 
testing.  I would like to know what you think about the implementation of routine HIV testing in your health 
care setting to help me know whether the clinic is meeting the patients’ needs and to help to improve these 
services.  This survey is completely anonymous.  Your name will not be used, and your participation is 
voluntary. You can skip any questions that you do not want to answer.  The questionnaire will take about 10 




Please complete the following questions. 
1. What is your primary profession or role? (Check one response)  
 
 Case Manager  
 Nurse Practitioner 
 Nursing Assistant  
 Phlebotomist 
 Physician 
 Resident Physician 
 Manager or Administrator 
 Front Desk Clerk or Receptionist  
 HIV Counselor 
 Lab Technician 
 Nurse 
 Physician Assistant 
 Psychologist 
 Social Worker 




2. What is your role in routine HIV testing? (Check all that apply)  
 Management or administrative role in routine HIV testing 
 Supervise staff conducting HIV testing 
 Conduct HIV testing 
 Provide health care services for patients who have received routine HIV testing or       screening 
  Teach other health care providers or students about routine HIV testing  
 No role in routine HIV testing 





Circle one response for each of the following items that best describes your personal 












1. I think routine HIV testing is an 
important part of regular health care.  1 2 3 4 5 
Don’t 
Know  NA  
2. I am concerned about cost and 
reimbursement for HIV testing.  1 2 3 4 5 
Don’t 
Know  NA  
3. I am concerned that patients will be 
offended by being offered routine HIV 
testing.  
1 2 3 4 5 Don’t 
Know  NA  
4. I am comfortable discussing routine 
HIV testing with patients.  1 2 3 4 5 
Don’t 
Know  NA  
5. Language barriers prevent some 
patients from receiving routine HIV 
testing.  
1 2 3 4 5 Don’t 
Know  NA  
6. Patients often feel like they have to 
accept routine HIV testing.  1 2 3 4 5 
Don’t 
Know  NA  
7. Patients receive adequate pre-test 
information for routine HIV testing.  
1 2 3 4 5 Don’t 
Know  
NA  
8. Patients receive adequate post-test 
information for routine HIV testing.  1 2 3 4 5 
Don’t 
Know  NA  
9. Patients are concerned about the 
confidentiality of routine HIV testing.  1 2 3 4 5 
Don’t 
Know  NA  
10. Routine HIV testing is voluntary; 
patients are able to decline screening.  1 2 3 4 5 
Don’t 
Know  NA  
11. Patients do not expect to be offered 
routine HIV testing.  




12. I am concerned that routine HIV 
testing will have a negative effect on 
patients’ opinions about our clinic. 




13. We have the resources needed to 
implement routine HIV testing. 




14. It is difficult to provide the privacy 
needed for routine HIV testing.  











Circle one response for each of the following items that best describes your personal 
perspectives about routine HIV testing in your work setting.  Please note that the 
response scale has changed. 













1. Routine HIV testing interferes with 
providing other health care services.  1 2 3 4 5 
Don’t 
Know  NA  
2. Patients are given HIV test results in a 
confidential, appropriate manner.  1 2 3 4 5 
Don’t 
Know  NA  
3. Results of routine HIV testing are 
documented and available to health care 
providers taking care of the patient.  
1 2 3 4 5 
Don’t 
Know  NA  
4. Patients are concerned or upset by routine 
HIV testing.  1 2 3 4 5 
Don’t 
Know  NA  
5. The presence of family members and 
visitors makes it difficult to discuss routine 
HIV testing with patients.  
1 2 3 4 5 Don’t 
Know  NA  
6. Patients understand the information they 
receive about routine HIV testing.  1 2 3 4 5 
Don’t 
Know  NA  
7. Patients who test 
HIV positive receive appropriate referrals for 
follow up  











Centers for Disease Control and Prevention. (2012) Evaluation toolkit: patient and provider perspectives about 






APPENDIX 5: POST-INTERVENTION SURVEY SECTION D. 
For Post-Intervention Survey Only 
Section B. 
1.  List any benefits or positive outcomes that have resulted from the 




2.  List any problems or negative outcomes that have resulted from the 




3.  Share any other comments about this questionnaire or about the 
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An independent, volunteer panel of national experts 
in prevention and evidence-based medicine 
U.S. Preventive Services Task Force Issues Draft 
Recommendation Statements on HIV Screening and Prevention  
Clinicians should screen for HIV in adolescents, adults, and pregnant women and  
offer PrEP to people at high risk for HIV 
WASHINGTON, D.C. – November 20, 2018 – The U.S. Preventive Services Task Force (Task Force) 
today posted draft recommendation statements and evidence reports on screening for and prevention 
of HIV. Based on its review of the evidence, the Task Force 
recommends that clinicians screen everyone ages 15 to 65 
years and all pregnant women for HIV. Younger adolescents 
and older adults at increased risk for HIV should also be 
screened. In a separate draft recommendation, the Task Force 
recommends that clinicians offer pre-exposure prophylaxis 
(PrEP)—a daily pill that helps prevent HIV—to people at high 
risk of HIV. These are A recommendations.  
Grade in these recommendations: 
A:  Recommended. 
Learn more here 
HIV is a virus that attacks cells that help the body fight infection, making a person more vulnerable to 
other infections and diseases. HIV is spread by contact with certain bodily fluids of a person infected 
with HIV, most commonly during sex without a condom or injection drug use.  
HIV continues to be a significant public health issue. While HIV infection rates, including mother-to-
baby transmission, have been going down, rates among some groups are on the rise, most notably 
among people ages 25 to 29 years. 
Screening for HIV 
Screening for HIV is the only way to know if a person has been infected with HIV because, after initial 
flu-like symptoms, HIV does not cause any signs or symptoms for several years. Screening tests are 
safe and effective at detecting HIV. There are two ways a clinician can test a person for HIV: a 
conventional blood test sent to the laboratory for analysis or a rapid test (finger prick or saliva swab) 
that provides results in less than 15 minutes.  
“About 40,000 people are diagnosed with HIV each year. This is why the Task Force, once again, calls 
for universal screening for HIV in adolescents and adults ages 15 to 65 years and in all pregnant 
women,” says Task Force member John Epling, M.D., M.S.Ed. “People deserve to know their HIV 
status so, if needed, they can start treatment early and live long, healthy lives.” 
People who learn that they have HIV need to start treatment as soon as possible to suppress the virus 
(keep the amount of HIV in the blood very low) and prevent HIV-related disease. Treatment also helps 
to reduce the chance that a person with HIV can pass the infection to another person. 
People younger than age 15 years or older than age 65 years should also be screened if they are at 
increased risk for HIV. Behaviors that increase someone’s risk include having a new sex partner whose 
HIV status is unknown.  
PrEP for HIV Prevention  
In addition to screening, people need to take steps to prevent getting HIV by wearing condoms during 
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